{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc.genefamily-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
    },
    "path": "mtor/ryskalin2018.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, further investigation on the autophagy pathway revealed that all these misfolded proteins are autophagy substrates depending on mTOR activity",
      "key": "c08a193528adfbd2ab35d81e7b4a3dd7",
      "line": 81,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 46,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, a common pathogenesis underlying all these NDDs disorders has been linked to autophagy inhibition due to mTOR hyperactivation",
      "key": "fc4cf5490f1f51165471129a196dccc3",
      "line": 98,
      "relation": "decreases",
      "source": 46,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, a common pathogenesis underlying all these NDDs disorders has been linked to autophagy inhibition due to mTOR hyperactivation",
      "key": "47b22a385470d38596136d0c99ab2970",
      "line": 99,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 46,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The relevance of autophagy for sustaining these mTOR-induced effects is confirmed by drugs inducing autophagy independently of mTOR activation",
      "key": "b5f62e839f2e7e3c71c763aaee4f61fa",
      "line": 265,
      "object": {
        "modifier": "Activity"
      },
      "relation": "regulates",
      "source": 46,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In fact, mTOR-induced autophagy inhibition exacerbates the ultrastructural effects of METH [126,134–136], while rapamycin administration reverts both behavioral and morphological alterations induced by METH [137].",
      "key": "5d0cb5c81ea8de900c4d3bc4d468008d",
      "line": 205,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 46,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This confirms our previous studies showing that both genetic and pharmacological autophagy inhibition worsen the effects of METH administration",
      "key": "d00b7ab3303f4145143b6cebfcdb70ba",
      "line": 299,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 46,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Noteworthy, genetic ablation of autophagy was shown to produce an extremely powerful DA release upon electrical stimuli, suggesting that autophagy is key to restrain DA release both upon basal neural activity and mostly after rapamycin-induced autophagy",
      "key": "c14c78f3434ca7431882beacd25747f5",
      "line": 280,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 46,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These findings strongly suggest that an autophagy dysfunction acts both at pre- and post-synaptic level to alter DA neurotransmission during both METH administration and schizophrenia (Figure 2)",
      "key": "af70000087f73d8da9bc67223c3ec3ef",
      "line": 292,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 46,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These findings strongly suggest that an autophagy dysfunction acts both at pre- and post-synaptic level to alter DA neurotransmission during both METH administration and schizophrenia (Figure 2)",
      "key": "9b34f0c04ad9477130a1f32e66f48fa4",
      "line": 291,
      "relation": "association",
      "source": 46,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the identification of rare genetic variants of ULK1 in a cohort of schizophrenic patients by means of exome sequence analysis strengthens the idea of a key role of both disrupted mTOR signaling and autophagy in the pathophysiology and susceptibility to schizophrenia",
      "key": "0d18faa44d7870ebd3fb3704fe77b62f",
      "line": 693,
      "relation": "negativeCorrelation",
      "source": 46,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "A few months later, another transcriptomic study reported a BA 22-specific down-regulation in several autophagy-related genes, thus strengthening the link between impaired autophagy and schizophrenia positive symptoms",
      "key": "613471de772bacaa56fcda9298ba5230",
      "line": 715,
      "relation": "negativeCorrelation",
      "source": 46,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Later on, further analysis reported a disruption of the autophagy pathway also in the hippocampus of post-mortem schizophrenic patients",
      "key": "5388febc3251bb2170b48a8828377808",
      "line": 724,
      "relation": "negativeCorrelation",
      "source": 46,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, at BA 22, the vast majority of abnormally expressed genes referred to key autophagy genes (i.e., BECN1, ULK2, ATG3), which were significantly down-regulated compared with controls",
      "key": "675cbb8248863a517d03e90142f6bccc",
      "line": 702,
      "relation": "association",
      "source": 46,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, at BA 22, the vast majority of abnormally expressed genes referred to key autophagy genes (i.e., BECN1, ULK2, ATG3), which were significantly down-regulated compared with controls",
      "key": "faf34543dba6fd3d2c886691b04888d5",
      "line": 704,
      "relation": "association",
      "source": 46,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, at BA 22, the vast majority of abnormally expressed genes referred to key autophagy genes (i.e., BECN1, ULK2, ATG3), which were significantly down-regulated compared with controls",
      "key": "6f9250bd2a52e47c937b2f7a28a004a0",
      "line": 706,
      "relation": "association",
      "source": 46,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "A few months later, another transcriptomic study reported a BA 22-specific down-regulation in several autophagy-related genes, thus strengthening the link between impaired autophagy and schizophrenia positive symptoms",
      "key": "070cedc8abcb2eed00b8309edf360c09",
      "line": 716,
      "relation": "negativeCorrelation",
      "source": 46,
      "target": 123
    },
    {
      "key": "528d9e1aac5db24e4d1245ab73b6180d",
      "relation": "hasVariant",
      "source": 106,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, further investigation on the autophagy pathway revealed that all these misfolded proteins are autophagy substrates depending on mTOR activity",
      "key": "71938b135f1c3c9cabc700aa17defbce",
      "line": 82,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "regulates",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, a common pathogenesis underlying all these NDDs disorders has been linked to autophagy inhibition due to mTOR hyperactivation",
      "key": "64295881910172fe5f09707b6c7a3b12",
      "line": 99,
      "relation": "negativeCorrelation",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In fact, mTOR-induced autophagy inhibition exacerbates the ultrastructural effects of METH [126,134–136], while rapamycin administration reverts both behavioral and morphological alterations induced by METH [137].",
      "key": "f961c3442f615b8cca357187743a36af",
      "line": 203,
      "relation": "decreases",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The biological implication behind an impairment of microtubule dynamics is confirmed in post-mortem schizophrenic brain samples, as well as in mouse models of schizophrenia, where mTOR-dependent autophagy dysfunction is accompanied by an altered gene expression and protein levels of the microtubule-associated protein 6 (MAP6)",
      "key": "33f9ebd0003f3ed7d74bb39f64e47178",
      "line": 477,
      "relation": "decreases",
      "source": 90,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, a common pathogenesis underlying all these NDDs disorders has been linked to autophagy inhibition due to mTOR hyperactivation",
      "key": "c4b0f98c626196d51c24cc214e2a6772",
      "line": 100,
      "relation": "positiveCorrelation",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "For instance, an increased mTOR activity correlates with accumulation of Abeta\f and hyperphosphorylated tau in AD brains",
      "key": "fc3b8664d9effcd2f450b09445d0c5bd",
      "line": 108,
      "relation": "increases",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "For instance, an increased mTOR activity correlates with accumulation of Abeta\f and hyperphosphorylated tau in AD brains",
      "key": "b0d089e44ccfad91a97ef03ca55c9182",
      "line": 109,
      "relation": "increases",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "On the other hand, some evidence indicates that suppressing mTOR activity ameliorates AD cognitive defects by decreasing Abeta\f and tau pathology",
      "key": "7ff810c18cdffc921d5359bca9866c9f",
      "line": 118,
      "relation": "increases",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "On the other hand, some evidence indicates that suppressing mTOR activity ameliorates AD cognitive defects by decreasing Abeta\f and tau pathology",
      "key": "9fbbcbf5850e02807732e01f01513cb7",
      "line": 119,
      "relation": "increases",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "On the other hand, some evidence indicates that suppressing mTOR activity ameliorates AD cognitive defects by decreasing Abeta\f and tau pathology",
      "key": "a024acad78a4bb7d51472c16c94bee26",
      "line": 121,
      "relation": "decreases",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "de20c46003b2f813597e3ed65ac985b9",
      "line": 194,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "5f440c4d455121b146eb0d9dcac463e9",
      "line": 195,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "533056b2b41597d588a48d28440a0263",
      "line": 196,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In fact, mTOR-induced autophagy inhibition exacerbates the ultrastructural effects of METH [126,134–136], while rapamycin administration reverts both behavioral and morphological alterations induced by METH [137].",
      "key": "3b1ba7d958720349ed9355c30ebd377f",
      "line": 204,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The biological implication behind an impairment of microtubule dynamics is confirmed in post-mortem schizophrenic brain samples, as well as in mouse models of schizophrenia, where mTOR-dependent autophagy dysfunction is accompanied by an altered gene expression and protein levels of the microtubule-associated protein 6 (MAP6)",
      "key": "fc82bf692513d1c2d00cebfffb42e2ac",
      "line": 478,
      "relation": "association",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The biological implication behind an impairment of microtubule dynamics is confirmed in post-mortem schizophrenic brain samples, as well as in mouse models of schizophrenia, where mTOR-dependent autophagy dysfunction is accompanied by an altered gene expression and protein levels of the microtubule-associated protein 6 (MAP6)",
      "key": "78785a668a0f341035bfe649110fad84",
      "line": 479,
      "relation": "association",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 87
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "d7104987fd56b7aca3ce26a4ec646f7e",
      "line": 617,
      "relation": "association",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "e2496d85bdc29347634328de07db9b25",
      "line": 619,
      "relation": "association",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the identification of rare genetic variants of ULK1 in a cohort of schizophrenic patients by means of exome sequence analysis strengthens the idea of a key role of both disrupted mTOR signaling and autophagy in the pathophysiology and susceptibility to schizophrenia",
      "key": "bf93f07817062791ed1e3e5a9ad2e076",
      "line": 692,
      "relation": "negativeCorrelation",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, most DLB patients show most features of AD (i.e., hyperphosphorylated tau deposits and A\fbeta) to various extents",
      "key": "badef2b7c91f16e2d8de6712decdcd60",
      "line": 89,
      "relation": "association",
      "source": 116,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, most DLB patients show most features of AD (i.e., hyperphosphorylated tau deposits and A\fbeta) to various extents",
      "key": "3013a141f9cd085cbee82545116e81ce",
      "line": 90,
      "relation": "association",
      "source": 116,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, most DLB patients show most features of AD (i.e., hyperphosphorylated tau deposits and A\fbeta) to various extents",
      "key": "8d226976d4623e5df915b5e1bd170f18",
      "line": 89,
      "relation": "association",
      "source": 89,
      "target": 116
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, pathological deposition of hyperphosphorylated MAP-tau (MAPT), which is the hallmark of several neurodegenerative disorders such as AD and frontotemporal dementia (FTD), has been described in elderly subjects with schizophrenia",
      "key": "39521d5bbd994d4608d4416bbf670657",
      "line": 400,
      "relation": "positiveCorrelation",
      "source": 89,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, pathological deposition of hyperphosphorylated MAP-tau (MAPT), which is the hallmark of several neurodegenerative disorders such as AD and frontotemporal dementia (FTD), has been described in elderly subjects with schizophrenia",
      "key": "fa5e24591e0651da400d4aca51ea00cb",
      "line": 401,
      "relation": "positiveCorrelation",
      "source": 89,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, pathological deposition of hyperphosphorylated MAP-tau (MAPT), which is the hallmark of several neurodegenerative disorders such as AD and frontotemporal dementia (FTD), has been described in elderly subjects with schizophrenia",
      "key": "b1f8238515c41444942d9a32b04e1111",
      "line": 402,
      "relation": "positiveCorrelation",
      "source": 89,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Both administration of amphetamines and stimulation of D1R induce a significant increase of CDK5 gene expression and protein levels, which, at molecular level, associates with increased dendritic spine density and hyper-phosphorylation of the cytoskeletal tau protein",
      "key": "720efff0a6c6894a772c6706f364c344",
      "line": 662,
      "relation": "positiveCorrelation",
      "source": 89,
      "target": 76
    },
    {
      "key": "b5ef526ab5a17da51fd96bb875e02aac",
      "relation": "hasVariant",
      "source": 88,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, most DLB patients show most features of AD (i.e., hyperphosphorylated tau deposits and A\fbeta) to various extents",
      "key": "fa065b5bc78ea3a015222fabd3b3c7dd",
      "line": 90,
      "relation": "association",
      "source": 0,
      "target": 116
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, a common pathogenesis underlying all these NDDs disorders has been linked to autophagy inhibition due to mTOR hyperactivation",
      "key": "057503d092d56cc6b4dfe5073cb76005",
      "line": 100,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 118,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, pathological deposition of hyperphosphorylated MAP-tau (MAPT), which is the hallmark of several neurodegenerative disorders such as AD and frontotemporal dementia (FTD), has been described in elderly subjects with schizophrenia",
      "key": "eac7091bd50b2449ab605fc77ee4e320",
      "line": 400,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Again, rapamycin and rapalogs protect against toxicity produced by a number of misfolded proteins encompassing alpha synuclein, TDP43, and hyperphosphorylated tau ",
      "key": "5c4b98df58e5fade2c72326f0136ecb2",
      "line": 129,
      "relation": "decreases",
      "source": 12,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Again, rapamycin and rapalogs protect against toxicity produced by a number of misfolded proteins encompassing alpha synuclein, TDP43, and hyperphosphorylated tau ",
      "key": "4551972548ddd30c00dd15dc7eb5d2ad",
      "line": 130,
      "relation": "decreases",
      "source": 12,
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Again, rapamycin and rapalogs protect against toxicity produced by a number of misfolded proteins encompassing alpha synuclein, TDP43, and hyperphosphorylated tau ",
      "key": "fc307cbfd1ca6ec5794a0566ff991af0",
      "line": 131,
      "relation": "decreases",
      "source": 12,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This is further supported by mounting evidence obtained in rodent models, which demonstrate that rapamycin normalizes impaired social interactions and reverses behavioral defects",
      "key": "88fd1f2960adf18150bb531bdab74629",
      "line": 140,
      "relation": "increases",
      "source": 12,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This is further supported by mounting evidence obtained in rodent models, which demonstrate that rapamycin normalizes impaired social interactions and reverses behavioral defects",
      "key": "5b306d3ee36222102bfc11c4f59fe90b",
      "line": 141,
      "relation": "increases",
      "source": 12,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In fact, mTOR-induced autophagy inhibition exacerbates the ultrastructural effects of METH [126,134–136], while rapamycin administration reverts both behavioral and morphological alterations induced by METH [137].",
      "key": "ec293a0fadd0f7eb6dae116709c4175a",
      "line": 206,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 12,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Likewise, rapamycin was found to be beneficial for ameliorating psychotic symptoms",
      "key": "7e6d1fb0c5d2bb1099ebc00bbf8b9508",
      "line": 258,
      "relation": "decreases",
      "source": 12,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These pieces of evidence corroborate findings showing that several autophagy inducers, such as lithium, rapamycin, and Food and Drug Administration (FDA) approved antipsychotic drugs are effective to treat psychosis including schizophrenia",
      "key": "ac9e924cec1efb74a29acb5c76f75be5",
      "line": 785,
      "relation": "decreases",
      "source": 12,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Noteworthy, genetic ablation of autophagy was shown to produce an extremely powerful DA release upon electrical stimuli, suggesting that autophagy is key to restrain DA release both upon basal neural activity and mostly after rapamycin-induced autophagy",
      "key": "40f6820f3bdea469133f44bb9c89bac1",
      "line": 281,
      "relation": "increases",
      "source": 12,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These pieces of evidence corroborate findings showing that several autophagy inducers, such as lithium, rapamycin, and Food and Drug Administration (FDA) approved antipsychotic drugs are effective to treat psychosis including schizophrenia",
      "key": "2b9f76b26d4a18a26df4e5e73aeabd8d",
      "line": 784,
      "relation": "decreases",
      "source": 12,
      "target": 124
    },
    {
      "key": "dccd33027ba2d4bd91b072af3b33efeb",
      "relation": "hasVariant",
      "source": 96,
      "target": 97
    },
    {
      "key": "f330221a26c90e449c53889c40f0191c",
      "relation": "hasVariant",
      "source": 96,
      "target": 98
    },
    {
      "key": "4bfef723bccb3358b2d8a6026ff0067a",
      "relation": "hasVariant",
      "source": 99,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, a very recent neuropathological examination provided evidence for TDP-43-positive cytosolic inclusions and dystrophic neurites in the brain of a patient diagnosed with FTLD presenting brief psychotic episodes and catatonia, which is a syndrome related to schizophrenia",
      "key": "888fd2c0e4a6d299d40a4e59c61a6f1e",
      "line": 428,
      "relation": "association",
      "source": 99,
      "subject": {
        "location": {
          "name": "inclusion body",
          "namespace": "GO"
        }
      },
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, a very recent neuropathological examination provided evidence for TDP-43-positive cytosolic inclusions and dystrophic neurites in the brain of a patient diagnosed with FTLD presenting brief psychotic episodes and catatonia, which is a syndrome related to schizophrenia",
      "key": "f019d9485eeb033f53c74b7b958b0e9c",
      "line": 429,
      "relation": "association",
      "source": 99,
      "subject": {
        "location": {
          "name": "dystrophic neurite",
          "namespace": "CONSO"
        }
      },
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Again, rapamycin and rapalogs protect against toxicity produced by a number of misfolded proteins encompassing alpha synuclein, TDP43, and hyperphosphorylated tau ",
      "key": "3a589589f5c2927cb606a4201da3b184",
      "line": 132,
      "relation": "decreases",
      "source": 2,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Again, rapamycin and rapalogs protect against toxicity produced by a number of misfolded proteins encompassing alpha synuclein, TDP43, and hyperphosphorylated tau ",
      "key": "3c7514fd67d3977e6cc0c155e75081cd",
      "line": 133,
      "relation": "decreases",
      "source": 2,
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Again, rapamycin and rapalogs protect against toxicity produced by a number of misfolded proteins encompassing alpha synuclein, TDP43, and hyperphosphorylated tau ",
      "key": "542037f4830ca398a88d5411af34cc01",
      "line": 134,
      "relation": "decreases",
      "source": 2,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In schizophrenia, a progressive synaptic disorder is likely to promote neurodegeneration",
      "key": "059bfe1132435cc889cb25139741f6f1",
      "line": 147,
      "relation": "association",
      "source": 24,
      "subject": {
        "modifier": "Activity"
      },
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene encodes for the DISC1 ubiquitous protein, which is implicated in neurogenesis, neuronal migration, axon/dendrite, and synapse formation",
      "key": "9dcfb2edefe4d780b6cab5d99f15438d",
      "line": 499,
      "relation": "association",
      "source": 24,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In schizophrenia, a progressive synaptic disorder is likely to promote neurodegeneration",
      "key": "876c6ef641ea67d710ac56d0a0f1075d",
      "line": 147,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 111,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "As detailed in the following paragraph, METH exerts disruptive effects on DA neurotransmission, which translate into abnormal stimulation of post-synaptic DA receptors, mainly D1-type DA receptors (D1R), thus leading to non-canonical signaling cascades sustaining behavioral alterations that overlap with schizophrenia-like symptoms (i.e., visual and auditory hallucinations and delusions)",
      "key": "d022c2dd24f86bd92163d32baa418b4c",
      "line": 158,
      "relation": "decreases",
      "source": 9,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These findings strongly suggest that an autophagy dysfunction acts both at pre- and post-synaptic level to alter DA neurotransmission during both METH administration and schizophrenia (Figure 2)",
      "key": "78fe2a9e77a76bd4ba96f699066efed3",
      "line": 288,
      "relation": "association",
      "source": 9,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "As detailed in the following paragraph, METH exerts disruptive effects on DA neurotransmission, which translate into abnormal stimulation of post-synaptic DA receptors, mainly D1-type DA receptors (D1R), thus leading to non-canonical signaling cascades sustaining behavioral alterations that overlap with schizophrenia-like symptoms (i.e., visual and auditory hallucinations and delusions)",
      "key": "9a35f0d483fe4d8b47129f687d5094ea",
      "line": 159,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 9,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "As detailed in the following paragraph, METH exerts disruptive effects on DA neurotransmission, which translate into abnormal stimulation of post-synaptic DA receptors, mainly D1-type DA receptors (D1R), thus leading to non-canonical signaling cascades sustaining behavioral alterations that overlap with schizophrenia-like symptoms (i.e., visual and auditory hallucinations and delusions)",
      "key": "a518dfee7e09b174ef5f86a600707b61",
      "line": 160,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 9,
      "target": 82
    },
    {
      "annotations": {
        "Anatomy": {
          "ventral striatum": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In line with this, experimental models of DISC1 deficiency treated with METH show a significant potentiation of DA release, along with increased expression of D1R in the ventral striatum when compared with controls",
      "key": "d9a19052fb9e6f8407819c03a8b337d2",
      "line": 512,
      "relation": "increases",
      "source": 9,
      "target": 82
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "As detailed in the following paragraph, METH exerts disruptive effects on DA neurotransmission, which translate into abnormal stimulation of post-synaptic DA receptors, mainly D1-type DA receptors (D1R), thus leading to non-canonical signaling cascades sustaining behavioral alterations that overlap with schizophrenia-like symptoms (i.e., visual and auditory hallucinations and delusions)",
      "key": "b7c6a16c9f2ce75b0120ce3c0ee4d323",
      "line": 161,
      "relation": "increases",
      "source": 9,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "As detailed in the following paragraph, METH exerts disruptive effects on DA neurotransmission, which translate into abnormal stimulation of post-synaptic DA receptors, mainly D1-type DA receptors (D1R), thus leading to non-canonical signaling cascades sustaining behavioral alterations that overlap with schizophrenia-like symptoms (i.e., visual and auditory hallucinations and delusions)",
      "key": "83c6c0b1109d92bc89f01c78e89186c4",
      "line": 162,
      "relation": "increases",
      "source": 9,
      "target": 123
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "As detailed in the following paragraph, METH exerts disruptive effects on DA neurotransmission, which translate into abnormal stimulation of post-synaptic DA receptors, mainly D1-type DA receptors (D1R), thus leading to non-canonical signaling cascades sustaining behavioral alterations that overlap with schizophrenia-like symptoms (i.e., visual and auditory hallucinations and delusions)",
      "key": "4536dcf6aa14231e5942af9e29a91e93",
      "line": 163,
      "relation": "increases",
      "source": 9,
      "target": 122
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "c5d4e6636ac12c3ce78775abaf23c83e",
      "line": 191,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 9,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "ee4cc09515721100466ddc4b593b45a7",
      "line": 192,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 9,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "2b5213f982149723d0c7afe5dc252d85",
      "line": 193,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 9,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In humans, the sensitizing effects of prolonged chronic METH intake are considered a major determinant to the occurrence and relapse of psychoses, which mirror those occurring in schizophrenic patients",
      "key": "7dfd4c0f5ad664656784c93bccf42859",
      "line": 213,
      "relation": "increases",
      "source": 9,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Such an abnormal DA release produces peaks of extracellular DA, which cannot be taken up within nerve terminals, because METH inhibits and reverts the direction of the dopamine transporter (DAT).",
      "key": "cf90a18280a83b72b9b826fb801d58f2",
      "line": 239,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 9,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In line with this, recent studies suggest that DAT expression is significantly reduced in the midbrain of postmortem schizophrenic samples [150], which is reminiscent of the METH-addicted brain [151,152].",
      "key": "b6a1c3ae89fb64ca28b3c8c674e76f1f",
      "line": 252,
      "relation": "decreases",
      "source": 9,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Such an abnormal DA release produces peaks of extracellular DA, which cannot be taken up within nerve terminals, because METH inhibits and reverts the direction of the dopamine transporter (DAT).",
      "key": "b40cc902cdccc6fe7de2e57889aa4fd0",
      "line": 241,
      "object": {
        "location": {
          "name": "Nerve Endings",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 9,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These findings strongly suggest that an autophagy dysfunction acts both at pre- and post-synaptic level to alter DA neurotransmission during both METH administration and schizophrenia (Figure 2)",
      "key": "af3b1d0a9b590f264dff9b7b5577fa35",
      "line": 289,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 9,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In fact, METH produces a massive increase of endogenous intra-cytosolic DA levels by inhibiting and reverting the direction of the vesicular monoamine transporter type 2 (VMAT-2), thus disrupting the physiological storage of DA",
      "key": "df9493cfb9a8fe58ff98d7ad96feff43",
      "line": 313,
      "object": {
        "location": {
          "name": "cytosol",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 9,
      "target": 7
    },
    {
      "annotations": {
        "Anatomy": {
          "ventral striatum": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In line with this, experimental models of DISC1 deficiency treated with METH show a significant potentiation of DA release, along with increased expression of D1R in the ventral striatum when compared with controls",
      "key": "5c212f546bc618bd95f493ed8c0e5bd1",
      "line": 511,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 9,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In line with this, METH produces ultrastructural alterations reflecting dysfunctional autophagy flux, which are DA-dependent",
      "key": "ad889013be95931569adbd045448eef6",
      "line": 305,
      "relation": "decreases",
      "source": 9,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In fact, METH produces a massive increase of endogenous intra-cytosolic DA levels by inhibiting and reverting the direction of the vesicular monoamine transporter type 2 (VMAT-2), thus disrupting the physiological storage of DA",
      "key": "a5b71d5e25cae357c3de72502333c32a",
      "line": 314,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 9,
      "target": 94
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "A reduction in VMAT-2 gene expression and protein levels in DA neurons occurs in both METH models and schizophrenic patients, marking quite impressively the overlap between these disorders",
      "key": "141161b85af0de2fe55d1becc0053f8d",
      "line": 324,
      "relation": "negativeCorrelation",
      "source": 9,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "It is worth mentioning that freely diffusible intra-cytosolic DA can readily undergo auto-oxidation and produce a cascade of oxidative-related damage, which is bound to the neurotoxic effects of high doses of METH",
      "key": "2c76394b7f0ce999c082a795ee145bde",
      "line": 333,
      "relation": "increases",
      "source": 9,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Likewise, administration of either D1R agonists or METH enhances Akt activity and over-activates mTOR signaling",
      "key": "6facddd9dccd3f525bdeffdf46e98cc5",
      "line": 564,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 9,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Likewise, administration of either D1R agonists or METH enhances Akt activity and over-activates mTOR signaling",
      "key": "00f5540eb0c3e082fdc8e18792e08b6a",
      "line": 565,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 9,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These findings strongly suggest that an autophagy dysfunction acts both at pre- and post-synaptic level to alter DA neurotransmission during both METH administration and schizophrenia (Figure 2)",
      "key": "01f36d38b280a89ec448d3ef992ad2f5",
      "line": 288,
      "relation": "association",
      "source": 35,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These findings strongly suggest that an autophagy dysfunction acts both at pre- and post-synaptic level to alter DA neurotransmission during both METH administration and schizophrenia (Figure 2)",
      "key": "8338c226d140e4d2b246051ba8a7d98a",
      "line": 291,
      "relation": "association",
      "source": 35,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, DISC1 plays a key role in DA neurotransmission",
      "key": "b5b35e92b4b0ace621e398de5051842d",
      "line": 504,
      "relation": "association",
      "source": 35,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Increased activity of D1R is considered as a major determinant of neuropsychiatric alterations occurring in both METH models/abusers and in schizophrenia",
      "key": "dfc310be8186948abb1b7e06cec20753",
      "line": 172,
      "relation": "positiveCorrelation",
      "source": 82,
      "subject": {
        "modifier": "Activity"
      },
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This is key, because abnormal stimulation of D1R and subsequent signaling cascades were recently shown to produce an over-activation of mTOR and inhibition of the autophagy machinery",
      "key": "d3ec5b5b96f26a55e4f6ee58f3b0fd04",
      "line": 179,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 82,
      "subject": {
        "modifier": "Activity"
      },
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Likewise, administration of either D1R agonists or METH enhances Akt activity and over-activates mTOR signaling",
      "key": "a085ccce645cd1c59814702010b85dae",
      "line": 563,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 82,
      "subject": {
        "modifier": "Activity"
      },
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This is key, because abnormal stimulation of D1R and subsequent signaling cascades were recently shown to produce an over-activation of mTOR and inhibition of the autophagy machinery",
      "key": "ebd6a883d8eb2eefd7860254db052044",
      "line": 180,
      "relation": "decreases",
      "source": 82,
      "subject": {
        "modifier": "Activity"
      },
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Likewise, administration of either D1R agonists or METH enhances Akt activity and over-activates mTOR signaling",
      "key": "62f643eb0d7b51f20604d519ad470bab",
      "line": 562,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 82,
      "subject": {
        "modifier": "Activity"
      },
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Both administration of amphetamines and stimulation of D1R induce a significant increase of CDK5 gene expression and protein levels, which, at molecular level, associates with increased dendritic spine density and hyper-phosphorylation of the cytoskeletal tau protein",
      "key": "94f20f4b538733a60f65719977e7d05d",
      "line": 657,
      "relation": "increases",
      "source": 82,
      "subject": {
        "modifier": "Activity"
      },
      "target": 127
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Both administration of amphetamines and stimulation of D1R induce a significant increase of CDK5 gene expression and protein levels, which, at molecular level, associates with increased dendritic spine density and hyper-phosphorylation of the cytoskeletal tau protein",
      "key": "73c7a88f0b0d7381a53a340f35e39640",
      "line": 658,
      "relation": "increases",
      "source": 82,
      "subject": {
        "modifier": "Activity"
      },
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In detail, the activation of CDK5 by D1R occurs via proteolysis of p35, the binding partner of CDK5",
      "key": "3333a79e193354fc1d8bca2ac8d504b8",
      "line": 669,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 82,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "A few months later, another transcriptomic study reported a BA 22-specific down-regulation in several autophagy-related genes, thus strengthening the link between impaired autophagy and schizophrenia positive symptoms",
      "key": "16bd9da092f61942d5ed44105af4200f",
      "line": 716,
      "relation": "negativeCorrelation",
      "source": 123,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "As detailed in the following paragraph, METH exerts disruptive effects on DA neurotransmission, which translate into abnormal stimulation of post-synaptic DA receptors, mainly D1-type DA receptors (D1R), thus leading to non-canonical signaling cascades sustaining behavioral alterations that overlap with schizophrenia-like symptoms (i.e., visual and auditory hallucinations and delusions)",
      "key": "0348252e20fb3af3ec06adc1930be01a",
      "line": 164,
      "relation": "increases",
      "source": 124,
      "target": 123
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "As detailed in the following paragraph, METH exerts disruptive effects on DA neurotransmission, which translate into abnormal stimulation of post-synaptic DA receptors, mainly D1-type DA receptors (D1R), thus leading to non-canonical signaling cascades sustaining behavioral alterations that overlap with schizophrenia-like symptoms (i.e., visual and auditory hallucinations and delusions)",
      "key": "cc641964af77928d429cb5ed95a7f2ca",
      "line": 165,
      "relation": "increases",
      "source": 124,
      "target": 122
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Increased activity of D1R is considered as a major determinant of neuropsychiatric alterations occurring in both METH models/abusers and in schizophrenia",
      "key": "64e12b3d521ec6509839933ce84ff007",
      "line": 172,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 124,
      "target": 82
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "d38349d51aec90e35a6d59c260a35a12",
      "line": 188,
      "relation": "association",
      "source": 124,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This is the case of the disrupted in schizophrenia 1 (DISC1) gene, a schizophrenia-related gene, originally discovered in a large Scottish family with a high incidence of psychiatric symptoms",
      "key": "c5e81f9a79033a01e2cbfe73561bb49b",
      "line": 488,
      "relation": "association",
      "source": 124,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "616301a1e81ce0444ee8cf7b011c59df",
      "line": 189,
      "relation": "association",
      "source": 124,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "b8c69f06d2a96ec1e4939bc91d2b8e5b",
      "line": 190,
      "relation": "association",
      "source": 124,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Another identified susceptibility gene for schizophrenia is the dihydropyrimidinase-like 2 (DPYSL2) gene",
      "key": "053379d64d4b258403f8855c9b6ddf9b",
      "line": 634,
      "relation": "association",
      "source": 124,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In humans, the sensitizing effects of prolonged chronic METH intake are considered a major determinant to the occurrence and relapse of psychoses, which mirror those occurring in schizophrenic patients",
      "key": "6164e8231bcc6818b1f79b600ccef0c7",
      "line": 214,
      "relation": "association",
      "source": 124,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Accordingly, clinical evidence points towards an elevation of pre-synaptic DA synthesis and release as a key event for schizophrenia",
      "key": "77aca263ba0ba3d2d829057690c866b3",
      "line": 220,
      "relation": "positiveCorrelation",
      "source": 124,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Accordingly, clinical evidence points towards an elevation of pre-synaptic DA synthesis and release as a key event for schizophrenia",
      "key": "f77d8136b603b4006cbafff497d1f32f",
      "line": 221,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 124,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Likewise, the psychostimulant effects experienced by METH-addicted patients rely on increased DA synthesis and massive DA release from nerve terminals within limbic areas as occurring in the schizophrenic brain",
      "key": "13965cc0022d66aa29d046101bef2237",
      "line": 229,
      "relation": "increases",
      "source": 124,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Likewise, the psychostimulant effects experienced by METH-addicted patients rely on increased DA synthesis and massive DA release from nerve terminals within limbic areas as occurring in the schizophrenic brain",
      "key": "91e5ff953be4b520cc0704cb13289d94",
      "line": 230,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Nerve Endings",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Limbic System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 124,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Mesencephalon": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In line with this, recent studies suggest that DAT expression is significantly reduced in the midbrain of postmortem schizophrenic samples [150], which is reminiscent of the METH-addicted brain [151,152].",
      "key": "b50eba39e9c499eaec1dd4a1f65a1447",
      "line": 249,
      "relation": "decreases",
      "source": 124,
      "target": 95
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "A reduction in VMAT-2 gene expression and protein levels in DA neurons occurs in both METH models and schizophrenic patients, marking quite impressively the overlap between these disorders",
      "key": "bc5562a661995045322fe90635ca848d",
      "line": 323,
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Beyond METH, redox-related changes that result from an imbalance between reactive oxygen species (ROS) production and ROS clearance are implicated in schizophrenia",
      "key": "7278f5c201ddaf5365004badaf30292a",
      "line": 340,
      "relation": "association",
      "source": 124,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, cytoskeletal derangement appears as a prominent feature of the ultrastructural pathology of schizophrenia",
      "key": "e636e5c7abca7dd07f167daf8a822acd",
      "line": 351,
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true,
          "Hippocampus": true,
          "Prefrontal Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Alterations in MAP2 immunoreactivity within the subiculum, entorhinal cortex, hippocampus, and prefrontal cortex have been suggested as the primary array of cytoskeletal abnormalities, which in turn result in impaired neurotransmission observed in schizophrenia",
      "key": "31795a3a14d74a78aaa12ec8bde5a2d0",
      "line": 381,
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Auditory Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Notably, a marked reduction in MAP2 immunoreactivity, along with a decrease in dendritic arbor, is reported in the primary auditory cortex (BA41) of schizophrenic subjects compared with healthy controls",
      "key": "7e2c75ec5a2d1a6f794fa91704daba59",
      "line": 390,
      "relation": "decreases",
      "source": 124,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Auditory Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Notably, a marked reduction in MAP2 immunoreactivity, along with a decrease in dendritic arbor, is reported in the primary auditory cortex (BA41) of schizophrenic subjects compared with healthy controls",
      "key": "768702d85ca1c5f610541148fdacd757",
      "line": 391,
      "relation": "decreases",
      "source": 124,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, pathological deposition of hyperphosphorylated MAP-tau (MAPT), which is the hallmark of several neurodegenerative disorders such as AD and frontotemporal dementia (FTD), has been described in elderly subjects with schizophrenia",
      "key": "7e55c1a47a9c796e7a562e085b97ddb5",
      "line": 402,
      "relation": "positiveCorrelation",
      "source": 124,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Momeni and colleagues (2010) recently reported two relatives with an early age at onset (27 and 29 years) of schizophrenic symptoms showing a marked neuronal tau deposition, as confirmed at pathological examination",
      "key": "f8ac8ae72e7c650ee908c3f9980a279e",
      "line": 409,
      "object": {
        "location": {
          "name": "Neurons",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 124,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Prefrontal Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Notably, post-mortem analysis performed in the prefrontal cortex of schizophrenic patients revealed oligodendrocyte ultrastructural abnormalities",
      "key": "952e687df803b3afdb9d7ce5d0a62e44",
      "line": 416,
      "relation": "decreases",
      "source": 124,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, a very recent neuropathological examination provided evidence for TDP-43-positive cytosolic inclusions and dystrophic neurites in the brain of a patient diagnosed with FTLD presenting brief psychotic episodes and catatonia, which is a syndrome related to schizophrenia",
      "key": "4b6aa47463bf1568b929d1602fed39c4",
      "line": 430,
      "relation": "association",
      "source": 124,
      "target": 121
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Preliminary in vitro studies demonstrated that two proteins, namely DISC1 and dysbindin-1, which are encoded by two susceptibility genes for schizophrenia, can form insoluble protein aggregates that are reminiscent of those occurring in neurodegenerative disorders",
      "key": "3a9efa95d7562a93d8e837c9261aa0d4",
      "line": 438,
      "relation": "association",
      "source": 124,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Intriguingly, the interactome analysis of both DISC1, dysbindin-1, and CRMP2, which is another susceptibility gene for schizophrenia, revealed common protein interactions with microtubules, actin cytoskeleton, and proteins involved in intracellular transport",
      "key": "a679822906a7607ef14c166d1c275a55",
      "line": 449,
      "relation": "association",
      "source": 124,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Preliminary in vitro studies demonstrated that two proteins, namely DISC1 and dysbindin-1, which are encoded by two susceptibility genes for schizophrenia, can form insoluble protein aggregates that are reminiscent of those occurring in neurodegenerative disorders",
      "key": "d388e20357da5a4d458bc605100701da",
      "line": 440,
      "relation": "association",
      "source": 124,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Intriguingly, the interactome analysis of both DISC1, dysbindin-1, and CRMP2, which is another susceptibility gene for schizophrenia, revealed common protein interactions with microtubules, actin cytoskeleton, and proteins involved in intracellular transport",
      "key": "e46aaead0974c8314531a6cbe2dc4288",
      "line": 452,
      "relation": "association",
      "source": 124,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Intriguingly, the interactome analysis of both DISC1, dysbindin-1, and CRMP2, which is another susceptibility gene for schizophrenia, revealed common protein interactions with microtubules, actin cytoskeleton, and proteins involved in intracellular transport",
      "key": "abe6d59ed97eaa05b64ae13b66ee247a",
      "line": 455,
      "relation": "association",
      "source": 124,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The biological implication behind an impairment of microtubule dynamics is confirmed in post-mortem schizophrenic brain samples, as well as in mouse models of schizophrenia, where mTOR-dependent autophagy dysfunction is accompanied by an altered gene expression and protein levels of the microtubule-associated protein 6 (MAP6)",
      "key": "cbfdd3485e17b71f9ae0490eac52e920",
      "line": 476,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Again, an impaired Akt signaling, achieved by neuronal deletion of rictor, a key regulatory subunit of mTORC2, contributes to schizophrenia-like phenotypes in rictor-null (KO) mice",
      "key": "482b83ad19e79cd9c2b4bde956303ba6",
      "line": 574,
      "relation": "association",
      "source": 124,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Prefrontal Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Dysregulation in Akt signaling and altered Akt protein levels were found in the frontal cortex and hippocampus of post-mortem brain samples from individuals affected by schizophrenia",
      "key": "a2074d7e48d43ef92b0ad8814032a1b2",
      "line": 584,
      "relation": "decreases",
      "source": 124,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "a60d9a5383f2c607ee37e59c47df3967",
      "line": 620,
      "relation": "association",
      "source": 124,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Prefrontal Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Dysregulation in Akt signaling and altered Akt protein levels were found in the frontal cortex and hippocampus of post-mortem brain samples from individuals affected by schizophrenia",
      "key": "7c7fdd76b5ffd9f7c07db4e7b97059b6",
      "line": 583,
      "relation": "decreases",
      "source": 124,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Furthermore, genetic linkage and association studies led to the identification of two additional susceptibility factors related to schizophrenia, such as neuregulin-1 (NRG1) and its receptor ErbB4",
      "key": "f51f3b4cd0287f8cdc9cf414e944df51",
      "line": 591,
      "relation": "association",
      "source": 124,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "b9a307bccaeed3dc4b19140dfc2b6f44",
      "line": 618,
      "relation": "association",
      "source": 124,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Furthermore, genetic linkage and association studies led to the identification of two additional susceptibility factors related to schizophrenia, such as neuregulin-1 (NRG1) and its receptor ErbB4",
      "key": "2b82a024044f4198fc2ceee64e83d558",
      "line": 592,
      "relation": "association",
      "source": 124,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "192a5e0c1c5b3cd06f534a94255346b5",
      "line": 619,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 124,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the identification of rare genetic variants of ULK1 in a cohort of schizophrenic patients by means of exome sequence analysis strengthens the idea of a key role of both disrupted mTOR signaling and autophagy in the pathophysiology and susceptibility to schizophrenia",
      "key": "26044b7145c09f25a2934b13c920c104",
      "line": 692,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the marked reduction of p35 levels in schizophrenic brains, which mirrors enhanced CDK5 activity [247], suggests a role for CDK5-CRMP2-dependent alterations of cytoskeleton architecture and psychiatric behavior",
      "key": "a1a5251d08eede1f6d59b9fa938880f6",
      "line": 679,
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the marked reduction of p35 levels in schizophrenic brains, which mirrors enhanced CDK5 activity [247], suggests a role for CDK5-CRMP2-dependent alterations of cytoskeleton architecture and psychiatric behavior",
      "key": "bf11bef33ed9ea83d8267f598547ae7d",
      "line": 680,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 124,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the identification of rare genetic variants of ULK1 in a cohort of schizophrenic patients by means of exome sequence analysis strengthens the idea of a key role of both disrupted mTOR signaling and autophagy in the pathophysiology and susceptibility to schizophrenia",
      "key": "e6bac82d95e43a576d0ee7a6ee67a34f",
      "line": 691,
      "relation": "association",
      "source": 124,
      "target": 103
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the identification of rare genetic variants of ULK1 in a cohort of schizophrenic patients by means of exome sequence analysis strengthens the idea of a key role of both disrupted mTOR signaling and autophagy in the pathophysiology and susceptibility to schizophrenia",
      "key": "6583eeb99ca6af789edc1a21951c7818",
      "line": 693,
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "A few months later, another transcriptomic study reported a BA 22-specific down-regulation in several autophagy-related genes, thus strengthening the link between impaired autophagy and schizophrenia positive symptoms",
      "key": "051917b8c710241326d979ff05effaef",
      "line": 715,
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Later on, further analysis reported a disruption of the autophagy pathway also in the hippocampus of post-mortem schizophrenic patients",
      "key": "a22a9ea9ebeaade1638b5599e20d248a",
      "line": 724,
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, at BA 22, the vast majority of abnormally expressed genes referred to key autophagy genes (i.e., BECN1, ULK2, ATG3), which were significantly down-regulated compared with controls",
      "key": "2841db31c11d85fe1537b6b900e00035",
      "line": 703,
      "relation": "decreases",
      "source": 124,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Immuno-histochemical analysis showed a three-fold decrease in the number of beclin1-positive cells in Map6+/- mice",
      "key": "1b5c41af7bcfe5755fedf887c76b4abe",
      "line": 759,
      "relation": "decreases",
      "source": 124,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, at BA 22, the vast majority of abnormally expressed genes referred to key autophagy genes (i.e., BECN1, ULK2, ATG3), which were significantly down-regulated compared with controls",
      "key": "7ce6b51f7d2f4e20d082f85a020d915d",
      "line": 705,
      "relation": "decreases",
      "source": 124,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, at BA 22, the vast majority of abnormally expressed genes referred to key autophagy genes (i.e., BECN1, ULK2, ATG3), which were significantly down-regulated compared with controls",
      "key": "4167ca07afb5fb67a4c0f3dfaab72059",
      "line": 707,
      "relation": "decreases",
      "source": 124,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In detail, the analysis of mRNA expression of a key protein for autophagy initiation, namely beclin1, revealed a significant region-specific reduction in hippocampal samples from 12 schizophrenic patients compared with 12 age-matched healthy controls.",
      "key": "a06361ed59852048a88ea2c4e564376c",
      "line": 733,
      "relation": "decreases",
      "source": 124,
      "target": 126
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "A reduction of ADNP and its homologous protein, ADNP2, is observed in schizophrenic patients [254], and it is recapitulated in Map6-deficient (Map6+/-) mice, another transgenic model of schizophrenia",
      "key": "a8b89b2a135eb40fda6ea444289efa4c",
      "line": 751,
      "relation": "decreases",
      "source": 124,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "A reduction of ADNP and its homologous protein, ADNP2, is observed in schizophrenic patients [254], and it is recapitulated in Map6-deficient (Map6+/-) mice, another transgenic model of schizophrenia",
      "key": "624c13568bb6d9c8de295bd569fd0d83",
      "line": 752,
      "relation": "decreases",
      "source": 124,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "8349d70763165639d969af84abc03e08",
      "line": 188,
      "relation": "association",
      "source": 64,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This is the case of the disrupted in schizophrenia 1 (DISC1) gene, a schizophrenia-related gene, originally discovered in a large Scottish family with a high incidence of psychiatric symptoms",
      "key": "2367dc6adb554897d746a5b7343f686b",
      "line": 488,
      "relation": "association",
      "source": 64,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "c493ec20a36e6bdadbb76e71b8be7c2f",
      "line": 194,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 64,
      "subject": {
        "modifier": "Activity"
      },
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "785575797d6e40cf14c4ed197d03461a",
      "line": 189,
      "relation": "association",
      "source": 66,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "f9e89396b47cf1f184473f4f18efdb74",
      "line": 195,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "6cd2511648d1e1b6a61c3b94dd183035",
      "line": 190,
      "relation": "association",
      "source": 65,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Another identified susceptibility gene for schizophrenia is the dihydropyrimidinase-like 2 (DPYSL2) gene",
      "key": "1428a6f9552aa68417934ac3ce65a54b",
      "line": 634,
      "relation": "association",
      "source": 65,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, several susceptibility genes for schizophrenia (e.g., DISC1, NRG1/ErbB4, and CRMP2), which are involved in either pre-synaptic DA release or post-synaptic D1R-related cascades, are similarly dysregulated by METH. Interestingly, they all converge on mTOR signaling (see Section 6, Table 1).",
      "key": "1d7e99787162b95dae3abcc22b0c0038",
      "line": 196,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 65,
      "subject": {
        "modifier": "Activity"
      },
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene is located on chromosome 8p21 and it encodes the cytosolic microtubule-associated protein CRMP2 (collapsin response mediator protein-2), which is highly expressed in the CNS and plays a role in axonal growth",
      "key": "8ab1af4f92baeebfa74dcc94debd3dad",
      "line": 642,
      "relation": "increases",
      "source": 65,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In humans, the sensitizing effects of prolonged chronic METH intake are considered a major determinant to the occurrence and relapse of psychoses, which mirror those occurring in schizophrenic patients",
      "key": "a8fd8063ea9941e4691cf4d825b70827",
      "line": 214,
      "relation": "association",
      "source": 120,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, the occurrence of alpha synuclein gene (SNCA) polymorphisms is associated with human METH psychosis [166].",
      "key": "f42f16e16019aae2c6228b5ab8220fab",
      "line": 345,
      "relation": "association",
      "source": 120,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, a very recent neuropathological examination provided evidence for TDP-43-positive cytosolic inclusions and dystrophic neurites in the brain of a patient diagnosed with FTLD presenting brief psychotic episodes and catatonia, which is a syndrome related to schizophrenia",
      "key": "aea8685a8f64c99a2e9dde49cf9f72b6",
      "line": 426,
      "relation": "association",
      "source": 120,
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Accordingly, clinical evidence points towards an elevation of pre-synaptic DA synthesis and release as a key event for schizophrenia",
      "key": "a311096b05ec2cfd3ec83e3ab9064e17",
      "line": 220,
      "relation": "positiveCorrelation",
      "source": 7,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Accordingly, clinical evidence points towards an elevation of pre-synaptic DA synthesis and release as a key event for schizophrenia",
      "key": "c8d7c910e7710cf884c61b083ac8eda7",
      "line": 221,
      "relation": "association",
      "source": 7,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In line with this, METH produces ultrastructural alterations reflecting dysfunctional autophagy flux, which are DA-dependent",
      "key": "db7ad6965d55240d3826f4b3d9039db7",
      "line": 306,
      "relation": "regulates",
      "source": 7,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In fact, METH produces a massive increase of endogenous intra-cytosolic DA levels by inhibiting and reverting the direction of the vesicular monoamine transporter type 2 (VMAT-2), thus disrupting the physiological storage of DA",
      "key": "1149b561980aecc097193722eff13904",
      "line": 315,
      "relation": "association",
      "source": 7,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "It is worth mentioning that freely diffusible intra-cytosolic DA can readily undergo auto-oxidation and produce a cascade of oxidative-related damage, which is bound to the neurotoxic effects of high doses of METH",
      "key": "ee1844cde053fc280931ec925d66120f",
      "line": 332,
      "relation": "increases",
      "source": 7,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Such an abnormal DA release produces peaks of extracellular DA, which cannot be taken up within nerve terminals, because METH inhibits and reverts the direction of the dopamine transporter (DAT).",
      "key": "c28c40545146269cba987001995df85c",
      "line": 240,
      "object": {
        "location": {
          "name": "Nerve Endings",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 95,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In fact, lithium is able to delay METH-induced sensitization, while being a powerful treatment in schizophrenia",
      "key": "67ccce258770207fd167c2cb299ba9b8",
      "line": 271,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 1,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In fact, lithium is able to delay METH-induced sensitization, while being a powerful treatment in schizophrenia",
      "key": "c296d2c4fb9c706c1fbbcd53d9fe112e",
      "line": 272,
      "relation": "decreases",
      "source": 1,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These pieces of evidence corroborate findings showing that several autophagy inducers, such as lithium, rapamycin, and Food and Drug Administration (FDA) approved antipsychotic drugs are effective to treat psychosis including schizophrenia",
      "key": "396aa22260bd79a2aa05932244fabdd6",
      "line": 782,
      "relation": "decreases",
      "source": 1,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These pieces of evidence corroborate findings showing that several autophagy inducers, such as lithium, rapamycin, and Food and Drug Administration (FDA) approved antipsychotic drugs are effective to treat psychosis including schizophrenia",
      "key": "a6c631038c512d81f33a1acb025dc652",
      "line": 783,
      "relation": "decreases",
      "source": 1,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In fact, METH produces a massive increase of endogenous intra-cytosolic DA levels by inhibiting and reverting the direction of the vesicular monoamine transporter type 2 (VMAT-2), thus disrupting the physiological storage of DA",
      "key": "9286f63981a12984ef1c5bbfdfa02fd7",
      "line": 315,
      "relation": "association",
      "source": 94,
      "target": 7
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "A reduction in VMAT-2 gene expression and protein levels in DA neurons occurs in both METH models and schizophrenic patients, marking quite impressively the overlap between these disorders",
      "key": "7263e504fea6697cd4d60af687415556",
      "line": 323,
      "relation": "negativeCorrelation",
      "source": 94,
      "target": 124
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "A reduction in VMAT-2 gene expression and protein levels in DA neurons occurs in both METH models and schizophrenic patients, marking quite impressively the overlap between these disorders",
      "key": "b728b35f20fa4329e95a94b4a3da8c7f",
      "line": 324,
      "relation": "negativeCorrelation",
      "source": 94,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Beyond METH, redox-related changes that result from an imbalance between reactive oxygen species (ROS) production and ROS clearance are implicated in schizophrenia",
      "key": "91bf073b2266450b6f541cb44ec6a72b",
      "line": 340,
      "relation": "association",
      "source": 3,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, the occurrence of alpha synuclein gene (SNCA) polymorphisms is associated with human METH psychosis [166].",
      "key": "6d9849e69d9acdb0c5b01cf9047832ce",
      "line": 345,
      "relation": "association",
      "source": 98,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, cytoskeletal derangement appears as a prominent feature of the ultrastructural pathology of schizophrenia",
      "key": "70738541c2df1cf02ce2ada924ca2e1d",
      "line": 351,
      "relation": "negativeCorrelation",
      "source": 33,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true,
          "Hippocampus": true,
          "Prefrontal Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Alterations in MAP2 immunoreactivity within the subiculum, entorhinal cortex, hippocampus, and prefrontal cortex have been suggested as the primary array of cytoskeletal abnormalities, which in turn result in impaired neurotransmission observed in schizophrenia",
      "key": "503fa869c288838e5cccb4bf9da81aef",
      "line": 380,
      "relation": "increases",
      "source": 33,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the marked reduction of p35 levels in schizophrenic brains, which mirrors enhanced CDK5 activity [247], suggests a role for CDK5-CRMP2-dependent alterations of cytoskeleton architecture and psychiatric behavior",
      "key": "89a7a27417d4786975df7e3f9e1ee0e8",
      "line": 682,
      "relation": "association",
      "source": 33,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Cytoskeleton organization and dynamics depend on the fine control of microtubule assembly, which relies on the interaction of microtubules with a specific class of proteins known as microtubule-associated protein (MAP).",
      "key": "e318facf02a83dbe45400b5349c81c8a",
      "line": 358,
      "relation": "increases",
      "source": 37,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Cytoskeleton organization and dynamics depend on the fine control of microtubule assembly, which relies on the interaction of microtubules with a specific class of proteins known as microtubule-associated protein (MAP).",
      "key": "01387cfe420e17bdf15ffe09a7d998d9",
      "line": 359,
      "relation": "increases",
      "source": 53,
      "target": 37
    },
    {
      "key": "d147099035461ffc36c282964382cd16",
      "relation": "partOf",
      "source": 23,
      "target": 53
    },
    {
      "key": "abf2f4e8c9c8de9617ef4b31a95a95fb",
      "relation": "partOf",
      "source": 23,
      "target": 54
    },
    {
      "key": "9160f9480c3899e2317b111c467eccdb",
      "relation": "partOf",
      "source": 23,
      "target": 56
    },
    {
      "key": "d8b603996fdcc95a4b6f662c05fb5d50",
      "relation": "partOf",
      "source": 23,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The biological implication behind an impairment of microtubule dynamics is confirmed in post-mortem schizophrenic brain samples, as well as in mouse models of schizophrenia, where mTOR-dependent autophagy dysfunction is accompanied by an altered gene expression and protein levels of the microtubule-associated protein 6 (MAP6)",
      "key": "706765fabef5c3237a68c53f30b70513",
      "line": 476,
      "relation": "negativeCorrelation",
      "source": 23,
      "subject": {
        "modifier": "Activity"
      },
      "target": 124
    },
    {
      "key": "ae5d1cc58b0f9381824d0c09906843ca",
      "relation": "partOf",
      "source": 26,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Dendrites": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Among various identified MAPs, microtubule-associated protein 2 (MAP2), which belongs to the MAP2/Tau family, is enriched in the brain and especially in dendrites, where it contributes to microtubule stabilization and overall dendritic architecture.",
      "key": "48c1fb7ca62d092d51be931787403155",
      "line": 368,
      "relation": "increases",
      "source": 86,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Dendrites": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Among various identified MAPs, microtubule-associated protein 2 (MAP2), which belongs to the MAP2/Tau family, is enriched in the brain and especially in dendrites, where it contributes to microtubule stabilization and overall dendritic architecture.",
      "key": "1844e0a39b80fa069b5a568ba0f6154d",
      "line": 369,
      "relation": "increases",
      "source": 86,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true,
          "Hippocampus": true,
          "Prefrontal Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Alterations in MAP2 immunoreactivity within the subiculum, entorhinal cortex, hippocampus, and prefrontal cortex have been suggested as the primary array of cytoskeletal abnormalities, which in turn result in impaired neurotransmission observed in schizophrenia",
      "key": "d4eb589e3f0fdfe5861fefa0f74d7a96",
      "line": 379,
      "relation": "increases",
      "source": 86,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true,
          "Hippocampus": true,
          "Prefrontal Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Alterations in MAP2 immunoreactivity within the subiculum, entorhinal cortex, hippocampus, and prefrontal cortex have been suggested as the primary array of cytoskeletal abnormalities, which in turn result in impaired neurotransmission observed in schizophrenia",
      "key": "4b2aa29df62555683d6b7f769d130835",
      "line": 381,
      "relation": "negativeCorrelation",
      "source": 40,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene encodes for the DISC1 ubiquitous protein, which is implicated in neurogenesis, neuronal migration, axon/dendrite, and synapse formation",
      "key": "146e2873adbb88539609a3cc83d38e7a",
      "line": 498,
      "relation": "association",
      "source": 22,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, pathological deposition of hyperphosphorylated MAP-tau (MAPT), which is the hallmark of several neurodegenerative disorders such as AD and frontotemporal dementia (FTD), has been described in elderly subjects with schizophrenia",
      "key": "3abce4afcc00c791211527a788ea39f0",
      "line": 401,
      "relation": "positiveCorrelation",
      "source": 113,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, a very recent neuropathological examination provided evidence for TDP-43-positive cytosolic inclusions and dystrophic neurites in the brain of a patient diagnosed with FTLD presenting brief psychotic episodes and catatonia, which is a syndrome related to schizophrenia",
      "key": "502ffd8221498635d7f6137bce5344ed",
      "line": 426,
      "relation": "association",
      "source": 114,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, a very recent neuropathological examination provided evidence for TDP-43-positive cytosolic inclusions and dystrophic neurites in the brain of a patient diagnosed with FTLD presenting brief psychotic episodes and catatonia, which is a syndrome related to schizophrenia",
      "key": "dbf8c7f2aa4d3758dc6ed436f3fd4579",
      "line": 427,
      "relation": "association",
      "source": 114,
      "target": 121
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, a very recent neuropathological examination provided evidence for TDP-43-positive cytosolic inclusions and dystrophic neurites in the brain of a patient diagnosed with FTLD presenting brief psychotic episodes and catatonia, which is a syndrome related to schizophrenia",
      "key": "e42c9cebbbd5b7aeb975ae82fbe03007",
      "line": 428,
      "object": {
        "location": {
          "name": "inclusion body",
          "namespace": "GO"
        }
      },
      "relation": "association",
      "source": 114,
      "target": 99
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, a very recent neuropathological examination provided evidence for TDP-43-positive cytosolic inclusions and dystrophic neurites in the brain of a patient diagnosed with FTLD presenting brief psychotic episodes and catatonia, which is a syndrome related to schizophrenia",
      "key": "d46a13cbe6068d53c9c8dec1f4f8b689",
      "line": 429,
      "object": {
        "location": {
          "name": "dystrophic neurite",
          "namespace": "CONSO"
        }
      },
      "relation": "association",
      "source": 114,
      "target": 99
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, a very recent neuropathological examination provided evidence for TDP-43-positive cytosolic inclusions and dystrophic neurites in the brain of a patient diagnosed with FTLD presenting brief psychotic episodes and catatonia, which is a syndrome related to schizophrenia",
      "key": "815f05ec917095d992901721a0d301e9",
      "line": 427,
      "relation": "association",
      "source": 121,
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, a very recent neuropathological examination provided evidence for TDP-43-positive cytosolic inclusions and dystrophic neurites in the brain of a patient diagnosed with FTLD presenting brief psychotic episodes and catatonia, which is a syndrome related to schizophrenia",
      "key": "10cc70372a9a57376412b2bcf3cafdbf",
      "line": 430,
      "relation": "association",
      "source": 121,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Preliminary in vitro studies demonstrated that two proteins, namely DISC1 and dysbindin-1, which are encoded by two susceptibility genes for schizophrenia, can form insoluble protein aggregates that are reminiscent of those occurring in neurodegenerative disorders",
      "key": "aff87c3b4eac6930e2183a15a04b8dd7",
      "line": 438,
      "relation": "association",
      "source": 79,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Intriguingly, the interactome analysis of both DISC1, dysbindin-1, and CRMP2, which is another susceptibility gene for schizophrenia, revealed common protein interactions with microtubules, actin cytoskeleton, and proteins involved in intracellular transport",
      "key": "12a9d07590fa836958ffc93ade750f9f",
      "line": 449,
      "relation": "association",
      "source": 79,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Preliminary in vitro studies demonstrated that two proteins, namely DISC1 and dysbindin-1, which are encoded by two susceptibility genes for schizophrenia, can form insoluble protein aggregates that are reminiscent of those occurring in neurodegenerative disorders",
      "key": "5b3eb0af640e5ce9832d70da482a6b84",
      "line": 439,
      "relation": "increases",
      "source": 79,
      "target": 16
    },
    {
      "key": "05f7142d9a1320fda554f933b2f52043",
      "relation": "partOf",
      "source": 79,
      "target": 54
    },
    {
      "key": "438ad712cc5aa0b1d9adb11587b63d44",
      "relation": "partOf",
      "source": 79,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene encodes for the DISC1 ubiquitous protein, which is implicated in neurogenesis, neuronal migration, axon/dendrite, and synapse formation",
      "key": "ddcc30455358efb4aa37bd0d4ba81e89",
      "line": 495,
      "relation": "association",
      "source": 79,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene encodes for the DISC1 ubiquitous protein, which is implicated in neurogenesis, neuronal migration, axon/dendrite, and synapse formation",
      "key": "c95bfd308d92a3ca35c5f6e11090b495",
      "line": 496,
      "relation": "association",
      "source": 79,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene encodes for the DISC1 ubiquitous protein, which is implicated in neurogenesis, neuronal migration, axon/dendrite, and synapse formation",
      "key": "ae377e3cee851bcd5832e04c9a4824bb",
      "line": 497,
      "relation": "association",
      "source": 79,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene encodes for the DISC1 ubiquitous protein, which is implicated in neurogenesis, neuronal migration, axon/dendrite, and synapse formation",
      "key": "69a56474919e027f4458632e407d4f91",
      "line": 498,
      "relation": "association",
      "source": 79,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene encodes for the DISC1 ubiquitous protein, which is implicated in neurogenesis, neuronal migration, axon/dendrite, and synapse formation",
      "key": "4008a7162747c1a8a5bf1ce7066eaed3",
      "line": 499,
      "relation": "association",
      "source": 79,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, DISC1 plays a key role in DA neurotransmission",
      "key": "5c8fbdb9a9a9261bcae597511ccca99b",
      "line": 504,
      "relation": "association",
      "source": 79,
      "target": 35
    },
    {
      "key": "2be90442175e526658ca55f5528e0ab5",
      "relation": "hasVariant",
      "source": 79,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, DISC1 acts by blocking KIAA1212, an Akt-binding partner, which directly interacts with Akt and strengthens the activation of this kinase, which represents a major mediator of the mTOR pathway.",
      "key": "5fe023b00e80f45fc41e5ef89c65d27d",
      "line": 527,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 79,
      "target": 75
    },
    {
      "key": "19d99ae5b47d7d2962f0000b47af13e5",
      "relation": "partOf",
      "source": 79,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Preliminary in vitro studies demonstrated that two proteins, namely DISC1 and dysbindin-1, which are encoded by two susceptibility genes for schizophrenia, can form insoluble protein aggregates that are reminiscent of those occurring in neurodegenerative disorders",
      "key": "81d2ef27e97553705b0e00e3b2821cec",
      "line": 442,
      "relation": "increases",
      "source": 16,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Preliminary in vitro studies demonstrated that two proteins, namely DISC1 and dysbindin-1, which are encoded by two susceptibility genes for schizophrenia, can form insoluble protein aggregates that are reminiscent of those occurring in neurodegenerative disorders",
      "key": "6e3de626e1591ac3d72a65e27a562217",
      "line": 440,
      "relation": "association",
      "source": 83,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Intriguingly, the interactome analysis of both DISC1, dysbindin-1, and CRMP2, which is another susceptibility gene for schizophrenia, revealed common protein interactions with microtubules, actin cytoskeleton, and proteins involved in intracellular transport",
      "key": "08215778bb05e88bf7b2bb4d0b3ed59d",
      "line": 452,
      "relation": "association",
      "source": 83,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Preliminary in vitro studies demonstrated that two proteins, namely DISC1 and dysbindin-1, which are encoded by two susceptibility genes for schizophrenia, can form insoluble protein aggregates that are reminiscent of those occurring in neurodegenerative disorders",
      "key": "56dddc8fd7572f6d814dd568254d47e9",
      "line": 441,
      "relation": "increases",
      "source": 83,
      "target": 16
    },
    {
      "key": "5e9af9127d2b5acb9ad090f83d8917b2",
      "relation": "partOf",
      "source": 83,
      "target": 56
    },
    {
      "key": "3e262f99345ecfd2b107de111c5f9e84",
      "relation": "partOf",
      "source": 83,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, CRMP2 is a cytosolic protein enriched in the CNS, which has been implicated in microtubule stabilization, and thus in the regulation of cytoskeletal dynamics and vesicle trafficking",
      "key": "9a6a5d9ae73824d5c0b95f766afa8af8",
      "line": 464,
      "relation": "association",
      "source": 83,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, CRMP2 is a cytosolic protein enriched in the CNS, which has been implicated in microtubule stabilization, and thus in the regulation of cytoskeletal dynamics and vesicle trafficking",
      "key": "d8ba18000dbd427e44d3352f6944cd74",
      "line": 465,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 83,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, CRMP2 is a cytosolic protein enriched in the CNS, which has been implicated in microtubule stabilization, and thus in the regulation of cytoskeletal dynamics and vesicle trafficking",
      "key": "c359e47a075055c6d40ff1c04e272fac",
      "line": 466,
      "relation": "association",
      "source": 83,
      "target": 45
    },
    {
      "key": "7586304f22f49e8aa4850a5baebfbb1f",
      "relation": "partOf",
      "source": 17,
      "target": 50
    },
    {
      "key": "491017c0891da5a5a2f3ea5039fa1b72",
      "relation": "partOf",
      "source": 17,
      "target": 52
    },
    {
      "key": "d8ff71f0e100f7e8297fa83a91535f88",
      "relation": "partOf",
      "source": 17,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Intriguingly, the interactome analysis of both DISC1, dysbindin-1, and CRMP2, which is another susceptibility gene for schizophrenia, revealed common protein interactions with microtubules, actin cytoskeleton, and proteins involved in intracellular transport",
      "key": "b24777ef47e6d39208c5635ceacebd74",
      "line": 455,
      "relation": "association",
      "source": 81,
      "target": 124
    },
    {
      "key": "807c4ca613eb9e9135100ec7ed9b7286",
      "relation": "partOf",
      "source": 81,
      "target": 55
    },
    {
      "key": "c8711311a7fac76ed8b85232616951f3",
      "relation": "partOf",
      "source": 81,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene is located on chromosome 8p21 and it encodes the cytosolic microtubule-associated protein CRMP2 (collapsin response mediator protein-2), which is highly expressed in the CNS and plays a role in axonal growth",
      "key": "d4f9c812017b7435598eb44ea782ad40",
      "line": 643,
      "relation": "association",
      "source": 81,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In line with this, the dendritic spine-regulating activity of CRMP2 is under the control of the cyclin-dependent kinase 5 (CDK5)",
      "key": "87487e6854aed1486bec66a23e4d4dc7",
      "line": 650,
      "relation": "regulates",
      "source": 81,
      "target": 18
    },
    {
      "key": "579ea2e9dce260ceffa3999af3ae59d5",
      "relation": "partOf",
      "source": 81,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, CRMP2 is a cytosolic protein enriched in the CNS, which has been implicated in microtubule stabilization, and thus in the regulation of cytoskeletal dynamics and vesicle trafficking",
      "key": "ad67e7eca731186c56ef5ca62c2e5baa",
      "line": 464,
      "relation": "association",
      "source": 19,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, CRMP2 is a cytosolic protein enriched in the CNS, which has been implicated in microtubule stabilization, and thus in the regulation of cytoskeletal dynamics and vesicle trafficking",
      "key": "538dd3069915aa91c2da408521dc20a6",
      "line": 465,
      "relation": "association",
      "source": 21,
      "subject": {
        "modifier": "Activity"
      },
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, CRMP2 is a cytosolic protein enriched in the CNS, which has been implicated in microtubule stabilization, and thus in the regulation of cytoskeletal dynamics and vesicle trafficking",
      "key": "67f8a0cc936e41cad1679b08c2bda0b6",
      "line": 466,
      "relation": "association",
      "source": 45,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The biological implication behind an impairment of microtubule dynamics is confirmed in post-mortem schizophrenic brain samples, as well as in mouse models of schizophrenia, where mTOR-dependent autophagy dysfunction is accompanied by an altered gene expression and protein levels of the microtubule-associated protein 6 (MAP6)",
      "key": "a7f364aba06a5439ac8ab6440d5b8e82",
      "line": 478,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 128,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The biological implication behind an impairment of microtubule dynamics is confirmed in post-mortem schizophrenic brain samples, as well as in mouse models of schizophrenia, where mTOR-dependent autophagy dysfunction is accompanied by an altered gene expression and protein levels of the microtubule-associated protein 6 (MAP6)",
      "key": "0db9d84642f11538794ebb2ab7927020",
      "line": 479,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 87,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene encodes for the DISC1 ubiquitous protein, which is implicated in neurogenesis, neuronal migration, axon/dendrite, and synapse formation",
      "key": "3b16d091b2d2aae27523b606171362d3",
      "line": 495,
      "relation": "association",
      "source": 49,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene encodes for the DISC1 ubiquitous protein, which is implicated in neurogenesis, neuronal migration, axon/dendrite, and synapse formation",
      "key": "d7bb9df5fdbe0190a2920a4a92ff6f2d",
      "line": 496,
      "relation": "association",
      "source": 39,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene encodes for the DISC1 ubiquitous protein, which is implicated in neurogenesis, neuronal migration, axon/dendrite, and synapse formation",
      "key": "f97c7f4741137ac71e200574e35773f3",
      "line": 497,
      "relation": "association",
      "source": 31,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This gene is located on chromosome 8p21 and it encodes the cytosolic microtubule-associated protein CRMP2 (collapsin response mediator protein-2), which is highly expressed in the CNS and plays a role in axonal growth",
      "key": "9224d41a9f929ed12857271f1cba43bf",
      "line": 643,
      "relation": "association",
      "source": 31,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, these findings strongly suggest that DISC1 alterations may increase the risk of schizophrenia by dysregulating DA release",
      "key": "6d05f6555f6fe7161e2f527a20fdfc46",
      "line": 519,
      "relation": "increases",
      "source": 80,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, disruption of DISC1 activity, due to genetic rearrangements (i.e., balanced (1;11) (q42;q14) chromosomal translocation) or missense mutations, produces schizophrenic-like behavior, which is bound to enhanced Akt activity, over-activation of mTOR signaling, and depressed autophagy",
      "key": "f414ad2f6998c185d141010123947454",
      "line": 553,
      "relation": "increases",
      "source": 80,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In addition, these findings strongly suggest that DISC1 alterations may increase the risk of schizophrenia by dysregulating DA release",
      "key": "a1077fbbd95e8103a18e8097f765f6cf",
      "line": 520,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 80,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, disruption of DISC1 activity, due to genetic rearrangements (i.e., balanced (1;11) (q42;q14) chromosomal translocation) or missense mutations, produces schizophrenic-like behavior, which is bound to enhanced Akt activity, over-activation of mTOR signaling, and depressed autophagy",
      "key": "90b5770f10cea158e1611e3c094bab8a",
      "line": 554,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 80,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, disruption of DISC1 activity, due to genetic rearrangements (i.e., balanced (1;11) (q42;q14) chromosomal translocation) or missense mutations, produces schizophrenic-like behavior, which is bound to enhanced Akt activity, over-activation of mTOR signaling, and depressed autophagy",
      "key": "2fcc4f94067b5b3560a88a664eaa7b04",
      "line": 555,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 80,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, disruption of DISC1 activity, due to genetic rearrangements (i.e., balanced (1;11) (q42;q14) chromosomal translocation) or missense mutations, produces schizophrenic-like behavior, which is bound to enhanced Akt activity, over-activation of mTOR signaling, and depressed autophagy",
      "key": "1eef3d29606d4992b527fb902b0740f3",
      "line": 556,
      "relation": "decreases",
      "source": 80,
      "target": 46
    },
    {
      "key": "1b2344c6803590d2a6a7522c421cc521",
      "relation": "partOf",
      "source": 75,
      "target": 57
    },
    {
      "key": "01d5ccf5544905a520c02602c5acd0ae",
      "relation": "partOf",
      "source": 75,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, the binding between DISC1 and KIAA1212 prevents KIAA1212-dependent Akt activation (Figure 3).",
      "key": "1fd2c0dc50213f2bcb9ce93d6ce77d86",
      "line": 536,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 75,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, DISC1 acts by blocking KIAA1212, an Akt-binding partner, which directly interacts with Akt and strengthens the activation of this kinase, which represents a major mediator of the mTOR pathway.",
      "key": "573e09b3b5ed16cef545441ac0b2f6a1",
      "line": 528,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 57,
      "target": 67
    },
    {
      "key": "0738e2fa8070b3443858f90ee7e307e4",
      "relation": "partOf",
      "source": 67,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, DISC1 acts by blocking KIAA1212, an Akt-binding partner, which directly interacts with Akt and strengthens the activation of this kinase, which represents a major mediator of the mTOR pathway.",
      "key": "ca5cfbf3141f3353d44724f01a068622",
      "line": 529,
      "object": {
        "modifier": "Activity"
      },
      "relation": "regulates",
      "source": 67,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This decreases Akt activity, which in turn dampens mTOR signaling",
      "key": "35ce2e413aceb9473b59d0ef01583629",
      "line": 545,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 67,
      "subject": {
        "modifier": "Activity"
      },
      "target": 90
    },
    {
      "key": "9dd8189a2b3a5de1bfa7880431999146",
      "relation": "hasVariant",
      "source": 67,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Therefore, the binding between DISC1 and KIAA1212 prevents KIAA1212-dependent Akt activation (Figure 3).",
      "key": "89c3121698e4e3861e5e774370307c18",
      "line": 535,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 60,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This decreases Akt activity, which in turn dampens mTOR signaling",
      "key": "321844c66d0b1db7ffdd5094596c0fef",
      "line": 543,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 60,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "This decreases Akt activity, which in turn dampens mTOR signaling",
      "key": "c3cae467a006a0359afcef657bb9ba02",
      "line": 544,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 60,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Again, an impaired Akt signaling, achieved by neuronal deletion of rictor, a key regulatory subunit of mTORC2, contributes to schizophrenia-like phenotypes in rictor-null (KO) mice",
      "key": "053e9adfe5b0fe4444fb19275482f32e",
      "line": 573,
      "relation": "decreases",
      "source": 110,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Again, an impaired Akt signaling, achieved by neuronal deletion of rictor, a key regulatory subunit of mTORC2, contributes to schizophrenia-like phenotypes in rictor-null (KO) mice",
      "key": "650634fb6bc03b25e4807a1525438b91",
      "line": 574,
      "relation": "association",
      "source": 43,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "da6a3b10b07bcd8132cc7594daf56f2e",
      "line": 620,
      "relation": "association",
      "source": 43,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "42c49e0e568c61c686bd3c7e64a9c3d1",
      "line": 616,
      "relation": "association",
      "source": 43,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Furthermore, genetic linkage and association studies led to the identification of two additional susceptibility factors related to schizophrenia, such as neuregulin-1 (NRG1) and its receptor ErbB4",
      "key": "6ac8c34a905b2dff4eb51fbd7d98db49",
      "line": 591,
      "relation": "association",
      "source": 91,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "a47e76f74765bbd66dde7b4dce9cfc04",
      "line": 618,
      "relation": "association",
      "source": 91,
      "target": 124
    },
    {
      "key": "dc48558ec575f8d8005299a70e1405a4",
      "relation": "partOf",
      "source": 91,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "7009f180f10623a1ed9154187fdab80b",
      "line": 615,
      "relation": "regulates",
      "source": 91,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "7907174957f30c0008e71bb507bd622a",
      "line": 616,
      "relation": "association",
      "source": 91,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Moreover, it has been demonstrated that NRG1 also regulates DISC1 expression [230], thus further worsening the aberrancy of the Akt–mTOR pathway and the pathogenesis of schizophrenia and related behaviors.",
      "key": "56bda08c15a8cb8fab4cdb788ebc0f5c",
      "line": 617,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 91,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Furthermore, genetic linkage and association studies led to the identification of two additional susceptibility factors related to schizophrenia, such as neuregulin-1 (NRG1) and its receptor ErbB4",
      "key": "a6be67edd562b7f092d09bc2b9524fbf",
      "line": 592,
      "relation": "association",
      "source": 84,
      "target": 124
    },
    {
      "key": "34bf2f081028286cfaa38a2518bc8162",
      "relation": "partOf",
      "source": 84,
      "target": 63
    },
    {
      "key": "896cab433b1c47955e2a367f82ce1c68",
      "relation": "partOf",
      "source": 84,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, NRG1, which is mostly involved in regulating neurodevelopment and neurotransmission, acts by binding ErbB4, a type I transmembrane receptor tyrosine kinase belonging to the family of ErbB proteins, which contain a binding site for PI3K kinase, an AKT upstream effector, in the C-terminal cytoplasmic tail (CYT)",
      "key": "0fd1785de536282fc623300de5c0a6bb",
      "line": 600,
      "relation": "regulates",
      "source": 63,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, NRG1, which is mostly involved in regulating neurodevelopment and neurotransmission, acts by binding ErbB4, a type I transmembrane receptor tyrosine kinase belonging to the family of ErbB proteins, which contain a binding site for PI3K kinase, an AKT upstream effector, in the C-terminal cytoplasmic tail (CYT)",
      "key": "e41b56de703722b813979221ea1b81f0",
      "line": 601,
      "relation": "regulates",
      "source": 63,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Corpus Striatum": true,
          "Hippocampus": true,
          "Prefrontal Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Noteworthy, NRG1/ErbB4 signaling plays a key role in DA-related behaviors by increasing DA release within the hippocampus, striatum, and prefrontal cortex",
      "key": "87ff309b83c5618dc1ce0c7c6a6530de",
      "line": 627,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 63,
      "subject": {
        "modifier": "Activity"
      },
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The binding between ErbB4 and PI3K activates this latter kinase, which in turn can phosphorylate and activate its downstream target Akt",
      "key": "f555b36cef800a73b18103da23766348",
      "line": 607,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 58,
      "target": 69
    },
    {
      "key": "45d3de39a4e214db78159151824b9f16",
      "relation": "partOf",
      "source": 69,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The binding between ErbB4 and PI3K activates this latter kinase, which in turn can phosphorylate and activate its downstream target Akt",
      "key": "b2081a89248d3e69df68193cb26088e7",
      "line": 608,
      "relation": "increases",
      "source": 69,
      "subject": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "The binding between ErbB4 and PI3K activates this latter kinase, which in turn can phosphorylate and activate its downstream target Akt",
      "key": "aaa16f0f3a480605ffa1dab604ebb79c",
      "line": 609,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 69,
      "subject": {
        "modifier": "Activity"
      },
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In line with this, the dendritic spine-regulating activity of CRMP2 is under the control of the cyclin-dependent kinase 5 (CDK5)",
      "key": "b249695f1d7b4bd48ae96521ffcac2c4",
      "line": 649,
      "relation": "regulates",
      "source": 76,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Both administration of amphetamines and stimulation of D1R induce a significant increase of CDK5 gene expression and protein levels, which, at molecular level, associates with increased dendritic spine density and hyper-phosphorylation of the cytoskeletal tau protein",
      "key": "de6db786d37270087a049b49834f0bdb",
      "line": 661,
      "relation": "positiveCorrelation",
      "source": 76,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Both administration of amphetamines and stimulation of D1R induce a significant increase of CDK5 gene expression and protein levels, which, at molecular level, associates with increased dendritic spine density and hyper-phosphorylation of the cytoskeletal tau protein",
      "key": "bf3866cfb57ab45c6b6fa9321a1c2d9c",
      "line": 662,
      "relation": "positiveCorrelation",
      "source": 76,
      "target": 89
    },
    {
      "key": "6abab7bd3d06d725b5751a82a0d51be3",
      "relation": "partOf",
      "source": 76,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the marked reduction of p35 levels in schizophrenic brains, which mirrors enhanced CDK5 activity [247], suggests a role for CDK5-CRMP2-dependent alterations of cytoskeleton architecture and psychiatric behavior",
      "key": "2eee60827d00aae1c1871626da463921",
      "line": 680,
      "relation": "positiveCorrelation",
      "source": 76,
      "subject": {
        "modifier": "Activity"
      },
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the marked reduction of p35 levels in schizophrenic brains, which mirrors enhanced CDK5 activity [247], suggests a role for CDK5-CRMP2-dependent alterations of cytoskeleton architecture and psychiatric behavior",
      "key": "c8a5da9def2c3266a71eba64632e6eb2",
      "line": 681,
      "relation": "negativeCorrelation",
      "source": 76,
      "subject": {
        "modifier": "Activity"
      },
      "target": 77
    },
    {
      "key": "94f9a703eb1043cbfd53dcbd380ce773",
      "relation": "partOf",
      "source": 76,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Both administration of amphetamines and stimulation of D1R induce a significant increase of CDK5 gene expression and protein levels, which, at molecular level, associates with increased dendritic spine density and hyper-phosphorylation of the cytoskeletal tau protein",
      "key": "b34fb31e04036871976ab7849a2220a5",
      "line": 661,
      "relation": "positiveCorrelation",
      "source": 18,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Both administration of amphetamines and stimulation of D1R induce a significant increase of CDK5 gene expression and protein levels, which, at molecular level, associates with increased dendritic spine density and hyper-phosphorylation of the cytoskeletal tau protein",
      "key": "c33680558d3b670c9dba92bdba8f9fec",
      "line": 659,
      "relation": "increases",
      "source": 4,
      "target": 127
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Both administration of amphetamines and stimulation of D1R induce a significant increase of CDK5 gene expression and protein levels, which, at molecular level, associates with increased dendritic spine density and hyper-phosphorylation of the cytoskeletal tau protein",
      "key": "dd287f6891c27be1ad53a89479a46186",
      "line": 660,
      "relation": "increases",
      "source": 4,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In detail, the activation of CDK5 by D1R occurs via proteolysis of p35, the binding partner of CDK5",
      "key": "1f9df649fb208063dd20fc5f6d330b22",
      "line": 670,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 78,
      "target": 76
    },
    {
      "key": "8c09df3b1c178a472197aed1da354af8",
      "relation": "hasVariant",
      "source": 77,
      "target": 78
    },
    {
      "key": "a3102cc72eabf02ae238ece2ff84fea4",
      "relation": "partOf",
      "source": 77,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the marked reduction of p35 levels in schizophrenic brains, which mirrors enhanced CDK5 activity [247], suggests a role for CDK5-CRMP2-dependent alterations of cytoskeleton architecture and psychiatric behavior",
      "key": "1f8e7699bd88828e870332db0f62adcc",
      "line": 679,
      "relation": "negativeCorrelation",
      "source": 77,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the marked reduction of p35 levels in schizophrenic brains, which mirrors enhanced CDK5 activity [247], suggests a role for CDK5-CRMP2-dependent alterations of cytoskeleton architecture and psychiatric behavior",
      "key": "6d0e40d7c7b78f3c3545e6b1bb87b865",
      "line": 681,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 77,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the marked reduction of p35 levels in schizophrenic brains, which mirrors enhanced CDK5 activity [247], suggests a role for CDK5-CRMP2-dependent alterations of cytoskeleton architecture and psychiatric behavior",
      "key": "25927bd34e9d2256433cda8defec4930",
      "line": 682,
      "relation": "association",
      "source": 62,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the marked reduction of p35 levels in schizophrenic brains, which mirrors enhanced CDK5 activity [247], suggests a role for CDK5-CRMP2-dependent alterations of cytoskeleton architecture and psychiatric behavior",
      "key": "2cbdceb053bb69b6f3b2aa84b66223bc",
      "line": 683,
      "relation": "association",
      "source": 62,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the marked reduction of p35 levels in schizophrenic brains, which mirrors enhanced CDK5 activity [247], suggests a role for CDK5-CRMP2-dependent alterations of cytoskeleton architecture and psychiatric behavior",
      "key": "c94231e2889b1dc9d0c0d4caf9ded761",
      "line": 683,
      "relation": "association",
      "source": 117,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Remarkably, the identification of rare genetic variants of ULK1 in a cohort of schizophrenic patients by means of exome sequence analysis strengthens the idea of a key role of both disrupted mTOR signaling and autophagy in the pathophysiology and susceptibility to schizophrenia",
      "key": "b1bd7d25e21c250ac74cd71950f5abf8",
      "line": 691,
      "relation": "association",
      "source": 103,
      "target": 124
    },
    {
      "key": "2060874150cac46c6ef8a81ad9c864fe",
      "relation": "hasVariant",
      "source": 101,
      "target": 103
    },
    {
      "key": "c5935c10c9c636b4c6fb849dd32918f9",
      "relation": "hasVariant",
      "source": 101,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, at BA 22, the vast majority of abnormally expressed genes referred to key autophagy genes (i.e., BECN1, ULK2, ATG3), which were significantly down-regulated compared with controls",
      "key": "37fdd3eab30f34adbcc3de380eb5e6a5",
      "line": 702,
      "relation": "association",
      "source": 73,
      "target": 46
    },
    {
      "key": "17e58009d2c10da9fcf0b34efc0e9882",
      "relation": "hasVariant",
      "source": 73,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, at BA 22, the vast majority of abnormally expressed genes referred to key autophagy genes (i.e., BECN1, ULK2, ATG3), which were significantly down-regulated compared with controls",
      "key": "8989410bf6b4ad36483ba5ec8080f329",
      "line": 704,
      "relation": "association",
      "source": 104,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, at BA 22, the vast majority of abnormally expressed genes referred to key autophagy genes (i.e., BECN1, ULK2, ATG3), which were significantly down-regulated compared with controls",
      "key": "aec16a6c9b6dd44150cdbfe042415eb5",
      "line": 706,
      "relation": "association",
      "source": 72,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "ADNP is an essential protein for brain development and it has been shown to physically interact with a key protein in autophagosome biogenesis and maturation, namely LC3",
      "key": "d2379c3c4b162ab65cddd1013cfc4996",
      "line": 741,
      "relation": "increases",
      "source": 70,
      "target": 32
    },
    {
      "key": "edb8e49bd8a1de5bc546fa4b061941f0",
      "relation": "partOf",
      "source": 70,
      "target": 59
    },
    {
      "key": "47be259ba3b433b07b2a921e2f66c56f",
      "relation": "partOf",
      "source": 85,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "ADNP is an essential protein for brain development and it has been shown to physically interact with a key protein in autophagosome biogenesis and maturation, namely LC3",
      "key": "89b2ae6b5c845f426585966759d7d700",
      "line": 743,
      "relation": "increases",
      "source": 85,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "ADNP is an essential protein for brain development and it has been shown to physically interact with a key protein in autophagosome biogenesis and maturation, namely LC3",
      "key": "0dd579bd964359ed2353b8244869df23",
      "line": 744,
      "relation": "increases",
      "source": 85,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "On the other hand, chronic treatment with an eight-amino-acid peptide snippet from ADNP (NAP), also known as davunetide, restored both Beclin1 and ADNP mRNA levels along with ADNP-LC3 interaction, thus providing neuroprotection while ameliorating schizophrenic-like behavioral and cognitive deficits in Map6+/- mice",
      "key": "ee83cfa2c3cde1d66d598b790e4a5781",
      "line": 768,
      "relation": "increases",
      "source": 28,
      "target": 126
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "On the other hand, chronic treatment with an eight-amino-acid peptide snippet from ADNP (NAP), also known as davunetide, restored both Beclin1 and ADNP mRNA levels along with ADNP-LC3 interaction, thus providing neuroprotection while ameliorating schizophrenic-like behavioral and cognitive deficits in Map6+/- mice",
      "key": "6fef64b33c9ce4ee95cfcbe9a01dcc1b",
      "line": 769,
      "relation": "increases",
      "source": 28,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "On the other hand, chronic treatment with an eight-amino-acid peptide snippet from ADNP (NAP), also known as davunetide, restored both Beclin1 and ADNP mRNA levels along with ADNP-LC3 interaction, thus providing neuroprotection while ameliorating schizophrenic-like behavioral and cognitive deficits in Map6+/- mice",
      "key": "89fd6afb1349f576abb3a3d926be7310",
      "line": 770,
      "relation": "increases",
      "source": 28,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "On the other hand, chronic treatment with an eight-amino-acid peptide snippet from ADNP (NAP), also known as davunetide, restored both Beclin1 and ADNP mRNA levels along with ADNP-LC3 interaction, thus providing neuroprotection while ameliorating schizophrenic-like behavioral and cognitive deficits in Map6+/- mice",
      "key": "78eaca00e412f7ae90e94a56237b005f",
      "line": 771,
      "relation": "decreases",
      "source": 28,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "On the other hand, chronic treatment with an eight-amino-acid peptide snippet from ADNP (NAP), also known as davunetide, restored both Beclin1 and ADNP mRNA levels along with ADNP-LC3 interaction, thus providing neuroprotection while ameliorating schizophrenic-like behavioral and cognitive deficits in Map6+/- mice",
      "key": "e0379d610f6d2d5b90c004ae96eb9a6c",
      "line": 772,
      "relation": "increases",
      "source": 28,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "On the other hand, chronic treatment with an eight-amino-acid peptide snippet from ADNP (NAP), also known as davunetide, restored both Beclin1 and ADNP mRNA levels along with ADNP-LC3 interaction, thus providing neuroprotection while ameliorating schizophrenic-like behavioral and cognitive deficits in Map6+/- mice",
      "key": "686b7689e34ffded696abb8b18f51b60",
      "line": 773,
      "relation": "decreases",
      "source": 28,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These pieces of evidence corroborate findings showing that several autophagy inducers, such as lithium, rapamycin, and Food and Drug Administration (FDA) approved antipsychotic drugs are effective to treat psychosis including schizophrenia",
      "key": "fa26f0a1bf3addd49035dbf6d9d3b265",
      "line": 786,
      "relation": "decreases",
      "source": 25,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "These pieces of evidence corroborate findings showing that several autophagy inducers, such as lithium, rapamycin, and Food and Drug Administration (FDA) approved antipsychotic drugs are effective to treat psychosis including schizophrenia",
      "key": "a2ae47ec839aab208581fa1faae78a22",
      "line": 787,
      "relation": "decreases",
      "source": 25,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Notably, high-throughput image-based screens performed by Zhang et al. (2007) [60] on a human glioblastoma H4 cell line expressing human LC3 coupled with green fluorescent protein (GFP) led us to disclose that three typical antipsychotic drugs (fluspirilene, trifluoperazine, and pimozide) are effective autophagy inducers.",
      "key": "90ec9aaa0c365b43bb9724ca543573f4",
      "line": 795,
      "relation": "increases",
      "source": 27,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Notably, high-throughput image-based screens performed by Zhang et al. (2007) [60] on a human glioblastoma H4 cell line expressing human LC3 coupled with green fluorescent protein (GFP) led us to disclose that three typical antipsychotic drugs (fluspirilene, trifluoperazine, and pimozide) are effective autophagy inducers.",
      "key": "c6cb7db334fdce397061169f42e7f89c",
      "line": 796,
      "relation": "increases",
      "source": 13,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Notably, high-throughput image-based screens performed by Zhang et al. (2007) [60] on a human glioblastoma H4 cell line expressing human LC3 coupled with green fluorescent protein (GFP) led us to disclose that three typical antipsychotic drugs (fluspirilene, trifluoperazine, and pimozide) are effective autophagy inducers.",
      "key": "5c5a6ba4644611c1ae9ef4a129eb055f",
      "line": 797,
      "relation": "increases",
      "source": 10,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "For instance, the increase in autophagy flux induced by pimozide occurs along with a depression of phosphorylated tau in a transgenic mouse model of AD ",
      "key": "dcee01ab167c11670fde00334897101d",
      "line": 846,
      "relation": "increases",
      "source": 10,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, pimozide provides an mTOR-independent autophagy induction, because it directly activates AMPK1, which in turn promotes autophagy through the phosphorylation of ULK1",
      "key": "f7d568e081c384c38c8b8135110beada",
      "line": 804,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 10,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "For instance, the increase in autophagy flux induced by pimozide occurs along with a depression of phosphorylated tau in a transgenic mouse model of AD ",
      "key": "c2ff6ea63a4d5c44de9be417e05852d1",
      "line": 847,
      "relation": "decreases",
      "source": 10,
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, pimozide provides an mTOR-independent autophagy induction, because it directly activates AMPK1, which in turn promotes autophagy through the phosphorylation of ULK1",
      "key": "82ed124878e8279f9d79f2ca6723f4d2",
      "line": 805,
      "relation": "increases",
      "source": 92,
      "subject": {
        "modifier": "Activity"
      },
      "target": 102
    },
    {
      "key": "4c45f9de32c5baf4974220d734a20b31",
      "relation": "hasVariant",
      "source": 92,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In particular, pimozide provides an mTOR-independent autophagy induction, because it directly activates AMPK1, which in turn promotes autophagy through the phosphorylation of ULK1",
      "key": "558ae2018ba338c45164f169a68641ba",
      "line": 806,
      "relation": "increases",
      "source": 102,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In contrast, chlorpromazine, which is a typical antipsychotic agent, induces autophagy by inhibiting the Akt/mTOR pathway",
      "key": "86a5d9ffd8938e6cbf40744ccf34cc44",
      "line": 812,
      "relation": "increases",
      "source": 5,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In contrast, chlorpromazine, which is a typical antipsychotic agent, induces autophagy by inhibiting the Akt/mTOR pathway",
      "key": "090c53dc09ffb5daf4a065846aa8a135",
      "line": 813,
      "relation": "decreases",
      "source": 5,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "In contrast, chlorpromazine, which is a typical antipsychotic agent, induces autophagy by inhibiting the Akt/mTOR pathway",
      "key": "958beb27fe964f211141034320b63c38",
      "line": 814,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Recently, in vitro studies on the effects of second-generation, atypical antipsychotics demonstrated that sertindole and clozapine are potent autophagy inducers in both neuronal and non-neuronal cell lines",
      "key": "1531d86b241d88bf5f5e73c8c6954e03",
      "line": 821,
      "relation": "increases",
      "source": 11,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Recently, in vitro studies on the effects of second-generation, atypical antipsychotics demonstrated that sertindole and clozapine are potent autophagy inducers in both neuronal and non-neuronal cell lines",
      "key": "f199e9f8f6e441584200cdea03aacd49",
      "line": 822,
      "relation": "increases",
      "source": 6,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Similar to pimozide, clozapine activates the autophagy process via the AMPK–ULK1–Beclin1 pathway, as evidenced by increased levels of autophagy markers (i.e., LC3-II and Atg5–Atg12 conjugate); increased phosphorylation of AMPK and its downstream substrates, namely ULK1 and beclin1; and an increased number of autophagosomes in the frontal cortex in clozapine-treated rats",
      "key": "2d961bd7ad4cffb297e070435d9f05f9",
      "line": 831,
      "relation": "increases",
      "source": 6,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Similar to pimozide, clozapine activates the autophagy process via the AMPK–ULK1–Beclin1 pathway, as evidenced by increased levels of autophagy markers (i.e., LC3-II and Atg5–Atg12 conjugate); increased phosphorylation of AMPK and its downstream substrates, namely ULK1 and beclin1; and an increased number of autophagosomes in the frontal cortex in clozapine-treated rats",
      "key": "5145eec72467b5a8e387937273debd00",
      "line": 832,
      "relation": "increases",
      "source": 6,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Similar to pimozide, clozapine activates the autophagy process via the AMPK–ULK1–Beclin1 pathway, as evidenced by increased levels of autophagy markers (i.e., LC3-II and Atg5–Atg12 conjugate); increased phosphorylation of AMPK and its downstream substrates, namely ULK1 and beclin1; and an increased number of autophagosomes in the frontal cortex in clozapine-treated rats",
      "key": "cab9ab39e82af6cd2fb23eb9cdb66302",
      "line": 833,
      "relation": "increases",
      "source": 6,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Similar to pimozide, clozapine activates the autophagy process via the AMPK–ULK1–Beclin1 pathway, as evidenced by increased levels of autophagy markers (i.e., LC3-II and Atg5–Atg12 conjugate); increased phosphorylation of AMPK and its downstream substrates, namely ULK1 and beclin1; and an increased number of autophagosomes in the frontal cortex in clozapine-treated rats",
      "key": "5004f02d7427a3e50c66b90baba35274",
      "line": 834,
      "relation": "increases",
      "source": 6,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Frontal Lobe": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Similar to pimozide, clozapine activates the autophagy process via the AMPK–ULK1–Beclin1 pathway, as evidenced by increased levels of autophagy markers (i.e., LC3-II and Atg5–Atg12 conjugate); increased phosphorylation of AMPK and its downstream substrates, namely ULK1 and beclin1; and an increased number of autophagosomes in the frontal cortex in clozapine-treated rats",
      "key": "a68b5ec0e37bb3846bf02e80a50b4bad",
      "line": 836,
      "relation": "increases",
      "source": 6,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "Chronic clozapine treatment (20 mg/kg/day) reduces Abeta\f deposition",
      "key": "1cbbf356eca1283f41f895247d7f576a",
      "line": 859,
      "relation": "decreases",
      "source": 6,
      "target": 0
    },
    {
      "key": "5dd6a708a892ff721c009091ebb1b773",
      "relation": "hasVariant",
      "source": 108,
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Busceti CL",
          "Fornai F",
          "Frati A",
          "Limanaqi F",
          "Ryskalin L"
        ],
        "date": "2018-07-30",
        "db": "PubMed",
        "db_id": "30061532",
        "db_name": "mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.",
        "first": "Ryskalin L",
        "journal": "International journal of molecular sciences",
        "last": "Fornai F",
        "volume": "19"
      },
      "evidence": "For instance, haloperidol occludes huntingtin aggregation",
      "key": "99279488d836dd0a50f2b089ab05ddee",
      "line": 854,
      "relation": "decreases",
      "source": 8,
      "target": 15
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(CHEBI:\"lithium(1+)\")",
      "concept": {
        "name": "lithium(1+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8831dd736dba764586a6f105da1c4efb"
    },
    {
      "bel": "a(CHEBI:\"mTOR inhibitor\")",
      "concept": {
        "name": "mTOR inhibitor",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "2759f5637c8761cbfa3a8b5b47684caa"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "concept": {
        "name": "reactive oxygen species",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "39a67bec2ea8cb7a2bec39cf66e565ba"
    },
    {
      "bel": "a(CHEBI:amphetamine)",
      "concept": {
        "name": "amphetamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "70f7aa8476ad73e327e325e1fd022a87"
    },
    {
      "bel": "a(CHEBI:chlorpromazine)",
      "concept": {
        "name": "chlorpromazine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9d857743b4153a7ed00e3232ee4bb197"
    },
    {
      "bel": "a(CHEBI:clozapine)",
      "concept": {
        "name": "clozapine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8e338a3b3012caca26fe7bc3f37245c9"
    },
    {
      "bel": "a(CHEBI:dopamine)",
      "concept": {
        "name": "dopamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4c950dc480c64069e58998401b2083c1"
    },
    {
      "bel": "a(CHEBI:haloperidol)",
      "concept": {
        "name": "haloperidol",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "33ed5b521c220e69175cf360a478f44e"
    },
    {
      "bel": "a(CHEBI:methamphetamine)",
      "concept": {
        "name": "methamphetamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f74fe5ca47fa46b0bd4e702c4ca0cf73"
    },
    {
      "bel": "a(CHEBI:pimozide)",
      "concept": {
        "name": "pimozide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ac984f36d8d2bc6d96d9851d8af2e6d3"
    },
    {
      "bel": "a(CHEBI:sertindole)",
      "concept": {
        "name": "sertindole",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "699d3899c9fd2a97822b5366a58385c5"
    },
    {
      "bel": "a(CHEBI:sirolimus)",
      "concept": {
        "name": "sirolimus",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "561f7408129243e1ed091f506ef0dded"
    },
    {
      "bel": "a(CHEBI:trifluoperazine)",
      "concept": {
        "name": "trifluoperazine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "992ec761789fbf0387aee609ada57a97"
    },
    {
      "bel": "a(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "8e1da50e6008ffdd1b37825776666311"
    },
    {
      "bel": "a(CONSO:\"huntingtin aggregates\")",
      "concept": {
        "name": "huntingtin aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "ddfb3dfcec37bcf8a1201a85c5723c38"
    },
    {
      "bel": "a(CONSO:\"protein aggregates\")",
      "concept": {
        "name": "protein aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "5b8103cc53d7c423f743808e9c9e45cb"
    },
    {
      "bel": "a(GO:\"actin cytoskeleton\")",
      "concept": {
        "name": "actin cytoskeleton",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "238973767e6234190e8e541c2472b73c"
    },
    {
      "bel": "a(GO:\"dendritic spine\")",
      "concept": {
        "name": "dendritic spine",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "54f7133fbca10891c48f5115bbc7757d"
    },
    {
      "bel": "a(GO:\"microtubule cytoskeleton\")",
      "concept": {
        "name": "microtubule cytoskeleton",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "fcc0ec584fd3597e141d6250716de66e"
    },
    {
      "bel": "a(GO:autophagosome)",
      "concept": {
        "name": "autophagosome",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "ba5dcaa249a37bedb6b206d83ac47484"
    },
    {
      "bel": "a(GO:cytoskeleton)",
      "concept": {
        "name": "cytoskeleton",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "51ad31d28e474c33008791d4c056bf13"
    },
    {
      "bel": "a(GO:dendrite)",
      "concept": {
        "name": "dendrite",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "6e388987593b13f2d2fc7c3afec44f37"
    },
    {
      "bel": "a(GO:microtubule)",
      "concept": {
        "name": "microtubule",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "0fe6be9622e5650da7dca7cdced2f9db"
    },
    {
      "bel": "a(GO:synapse)",
      "concept": {
        "name": "synapse",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "69c474d54609b66889d95380bd3d9a19"
    },
    {
      "bel": "a(MESH:\"Antipsychotic Agents\")",
      "concept": {
        "name": "Antipsychotic Agents",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "b19cbab6f8ca365ef32503a6c75e1701"
    },
    {
      "bel": "a(MESH:\"Microtubule-Associated Proteins\")",
      "concept": {
        "name": "Microtubule-Associated Proteins",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4047a861c82427a8305806ac13346353"
    },
    {
      "bel": "a(PUBCHEM:3396)",
      "concept": {
        "name": "3396",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "29a634a72f7de78fda79ebfb7525bebe"
    },
    {
      "bel": "a(PUBCHEM:9832404)",
      "concept": {
        "name": "9832404",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "3405fbce6f8f0c9592b3b53606464d2f"
    },
    {
      "bel": "bp(GO:\"autophagosome assembly\")",
      "concept": {
        "name": "autophagosome assembly",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "bd4c3cc9e6c9ac4d60d3e6b79c7c79dd"
    },
    {
      "bel": "bp(GO:\"autophagosome maturation\")",
      "concept": {
        "name": "autophagosome maturation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a2154e765824276e86e0708ac23af355"
    },
    {
      "bel": "bp(GO:\"axon development\")",
      "concept": {
        "name": "axon development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "cb264ad706c25d23fedde395dca1ca2f"
    },
    {
      "bel": "bp(GO:\"brain development\")",
      "concept": {
        "name": "brain development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ac0c7c6bcd68b7fc8d43fa1e094e68f6"
    },
    {
      "bel": "bp(GO:\"cytoskeleton organization\")",
      "concept": {
        "name": "cytoskeleton organization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "bb64577fbf45604676b746f34d8f6a5d"
    },
    {
      "bel": "bp(GO:\"dendritic spine organization\")",
      "concept": {
        "name": "dendritic spine organization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a0859e5d7d94bb316b837ab02141fcbb"
    },
    {
      "bel": "bp(GO:\"dopamine secretion, neurotransmission\")",
      "concept": {
        "name": "dopamine secretion, neurotransmission",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "118eb7065bd13c3f18a84cfbd0278eb4"
    },
    {
      "bel": "bp(GO:\"generation of neurons\")",
      "concept": {
        "name": "generation of neurons",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "0df1f54487a90beeac83692bb406f5a0"
    },
    {
      "bel": "bp(GO:\"microtubule polymerization\")",
      "concept": {
        "name": "microtubule polymerization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "689df6bb44a41b81144f3915d73a445a"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"neuron migration\")",
      "concept": {
        "name": "neuron migration",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b76e5f0647cf0e1b211efee1492cd36d"
    },
    {
      "bel": "bp(GO:\"neuron-neuron synaptic transmission\")",
      "concept": {
        "name": "neuron-neuron synaptic transmission",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "055b96da88d9a24a4c3816fc3e25c108"
    },
    {
      "bel": "bp(GO:\"non-canonical Wnt signaling pathway\")",
      "concept": {
        "name": "non-canonical Wnt signaling pathway",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "df9371981c4e82e0fffef8c856f1d77c"
    },
    {
      "bel": "bp(GO:\"oligodendrocyte development\")",
      "concept": {
        "name": "oligodendrocyte development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a010b71f27eb47e233435cc68a6d7a0e"
    },
    {
      "bel": "bp(GO:\"protein kinase B signaling\")",
      "concept": {
        "name": "protein kinase B signaling",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3eeaa6a71064ef03aaf7cd38656569a3"
    },
    {
      "bel": "bp(GO:\"response to oxidative stress\")",
      "concept": {
        "name": "response to oxidative stress",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d501b05a4babb0401c86b84d8abf2db7"
    },
    {
      "bel": "bp(GO:\"synaptic vesicle transport\")",
      "concept": {
        "name": "synaptic vesicle transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "dbdb5e01a1087a1e1cb7218e960573fc"
    },
    {
      "bel": "bp(GO:autophagy)",
      "concept": {
        "name": "autophagy",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9efc965fac6a195d0fad26eecddaac05"
    },
    {
      "bel": "bp(GO:behavior)",
      "concept": {
        "name": "behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "77f1822074b59deb82cc4661eb6d5aa5"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(MESH:Neurogenesis)",
      "concept": {
        "name": "Neurogenesis",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "84b1518fc209fe5711b46bc4dcba278e"
    },
    {
      "bel": "complex(a(GO:\"actin cytoskeleton\"), p(HGNC:DISC1))",
      "function": "Complex",
      "id": "22651b37e83b6c1682d20735743fa636",
      "members": [
        {
          "bel": "a(GO:\"actin cytoskeleton\")",
          "concept": {
            "name": "actin cytoskeleton",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "238973767e6234190e8e541c2472b73c"
        },
        {
          "bel": "p(HGNC:DISC1)",
          "concept": {
            "name": "DISC1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "119d7ded64ae942661a796d9d416306f"
        }
      ]
    },
    {
      "bel": "complex(a(GO:\"actin cytoskeleton\"), p(HGNC:DPYSL2))",
      "function": "Complex",
      "id": "19b71d124e0f181739fd411fa59d925c",
      "members": [
        {
          "bel": "a(GO:\"actin cytoskeleton\")",
          "concept": {
            "name": "actin cytoskeleton",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "238973767e6234190e8e541c2472b73c"
        },
        {
          "bel": "p(HGNC:DPYSL2)",
          "concept": {
            "name": "DPYSL2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "350bf2b3bff9a818ee59d1158e922f17"
        }
      ]
    },
    {
      "bel": "complex(a(GO:\"actin cytoskeleton\"), p(HGNC:DTNBP1))",
      "function": "Complex",
      "id": "179d88fb7537e470e608dd4b23cdaa76",
      "members": [
        {
          "bel": "a(GO:\"actin cytoskeleton\")",
          "concept": {
            "name": "actin cytoskeleton",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "238973767e6234190e8e541c2472b73c"
        },
        {
          "bel": "p(HGNC:DTNBP1)",
          "concept": {
            "name": "DTNBP1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "59c195c921e179c7267ba3a852fd18f8"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), a(MESH:\"Microtubule-Associated Proteins\"))",
      "function": "Complex",
      "id": "855a4b002d8214e4d8d151c901f03ad7",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "0fe6be9622e5650da7dca7cdced2f9db"
        },
        {
          "bel": "a(MESH:\"Microtubule-Associated Proteins\")",
          "concept": {
            "name": "Microtubule-Associated Proteins",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "4047a861c82427a8305806ac13346353"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), p(HGNC:DISC1))",
      "function": "Complex",
      "id": "9c44d12fa0be7c40c82e0d10efd17410",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "0fe6be9622e5650da7dca7cdced2f9db"
        },
        {
          "bel": "p(HGNC:DISC1)",
          "concept": {
            "name": "DISC1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "119d7ded64ae942661a796d9d416306f"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), p(HGNC:DPYSL2))",
      "function": "Complex",
      "id": "9c12603d7013755085afb7afc28211cd",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "0fe6be9622e5650da7dca7cdced2f9db"
        },
        {
          "bel": "p(HGNC:DPYSL2)",
          "concept": {
            "name": "DPYSL2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "350bf2b3bff9a818ee59d1158e922f17"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), p(HGNC:DTNBP1))",
      "function": "Complex",
      "id": "e3850700da70d9fdf5f47a6eeb7e5976",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "0fe6be9622e5650da7dca7cdced2f9db"
        },
        {
          "bel": "p(HGNC:DTNBP1)",
          "concept": {
            "name": "DTNBP1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "59c195c921e179c7267ba3a852fd18f8"
        }
      ]
    },
    {
      "bel": "complex(p(FPLX:AKT), p(HGNC:CCDC88A))",
      "function": "Complex",
      "id": "44f9c1660845e9c1753362f27437bd03",
      "members": [
        {
          "bel": "p(FPLX:AKT)",
          "concept": {
            "name": "AKT",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "e0ada1edbf208bbaa7cb0798a2462eb3"
        },
        {
          "bel": "p(HGNC:CCDC88A)",
          "concept": {
            "name": "CCDC88A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "9f58f6742d37b33cc08d9e29ada7c6fe"
        }
      ]
    },
    {
      "bel": "complex(p(FPLX:PI3K), p(HGNC:ERBB4))",
      "function": "Complex",
      "id": "60cbe0363d2a904a8eb636290ffa9fe0",
      "members": [
        {
          "bel": "p(FPLX:PI3K)",
          "concept": {
            "name": "PI3K",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "5af4f36e611a078c661859dca158efec"
        },
        {
          "bel": "p(HGNC:ERBB4)",
          "concept": {
            "name": "ERBB4",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "47fbed2d8914ddf8b9ea399ab49214d8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:ADNP), p(HGNC:MAP1LC3A))",
      "function": "Complex",
      "id": "dfce57770412ddabb3b775f504dbcede",
      "members": [
        {
          "bel": "p(HGNC:ADNP)",
          "concept": {
            "name": "ADNP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7e1eed65f362c8a67fb00752ee3a41cf"
        },
        {
          "bel": "p(HGNC:MAP1LC3A)",
          "concept": {
            "name": "MAP1LC3A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "89badabd301b21ede7de4f845c3e918f"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CCDC88A), p(HGNC:DISC1))",
      "function": "Complex",
      "id": "fdc50a73575c97e65b819e20b5032984",
      "members": [
        {
          "bel": "p(HGNC:CCDC88A)",
          "concept": {
            "name": "CCDC88A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "9f58f6742d37b33cc08d9e29ada7c6fe"
        },
        {
          "bel": "p(HGNC:DISC1)",
          "concept": {
            "name": "DISC1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "119d7ded64ae942661a796d9d416306f"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CDK5), p(HGNC:CDK5R1))",
      "function": "Complex",
      "id": "a75a86a0b69fcb55521ad3eb38344c51",
      "members": [
        {
          "bel": "p(HGNC:CDK5)",
          "concept": {
            "name": "CDK5",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "cb1e1b28f1d3fe30db837d601f26fe1b"
        },
        {
          "bel": "p(HGNC:CDK5R1)",
          "concept": {
            "name": "CDK5R1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "386aa7422eaa152faa763b873a474731"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CDK5), p(HGNC:DPYSL2))",
      "function": "Complex",
      "id": "4c2e4ca77da98171d45cf61ee8edb592",
      "members": [
        {
          "bel": "p(HGNC:CDK5)",
          "concept": {
            "name": "CDK5",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "cb1e1b28f1d3fe30db837d601f26fe1b"
        },
        {
          "bel": "p(HGNC:DPYSL2)",
          "concept": {
            "name": "DPYSL2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "350bf2b3bff9a818ee59d1158e922f17"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:ERBB4), p(HGNC:NRG1))",
      "function": "Complex",
      "id": "917cc340f53cda0624ed5918ff9d1940",
      "members": [
        {
          "bel": "p(HGNC:ERBB4)",
          "concept": {
            "name": "ERBB4",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "47fbed2d8914ddf8b9ea399ab49214d8"
        },
        {
          "bel": "p(HGNC:NRG1)",
          "concept": {
            "name": "NRG1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "340c84bad870d4aa1faafb6db24cf9ee"
        }
      ]
    },
    {
      "bel": "g(HGNC:DISC1)",
      "concept": {
        "name": "DISC1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "b527faf8d5051e5fef2f550753c19dbf"
    },
    {
      "bel": "g(HGNC:DPYSL2)",
      "concept": {
        "name": "DPYSL2",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "8a17047d4565d93a30c5a7d4f4113c4b"
    },
    {
      "bel": "g(HGNC:NRG1)",
      "concept": {
        "name": "NRG1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "0ca9343e39446d4dbd43648fdc4fc863"
    },
    {
      "bel": "p(FPLX:AKT)",
      "concept": {
        "name": "AKT",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "e0ada1edbf208bbaa7cb0798a2462eb3"
    },
    {
      "bel": "p(FPLX:AKT, pmod(Ph))",
      "concept": {
        "name": "AKT",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "4cd682f5a280ba91aeef5091781c4061",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:PI3K)",
      "concept": {
        "name": "PI3K",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "5af4f36e611a078c661859dca158efec"
    },
    {
      "bel": "p(HGNC:ADNP)",
      "concept": {
        "name": "ADNP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7e1eed65f362c8a67fb00752ee3a41cf"
    },
    {
      "bel": "p(HGNC:ADNP2)",
      "concept": {
        "name": "ADNP2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f6c86dcd246e8c5ae57e1cf5e6820e63"
    },
    {
      "bel": "p(HGNC:ATG3)",
      "concept": {
        "name": "ATG3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3e0c70f63264567ab922040edf94895e"
    },
    {
      "bel": "p(HGNC:BECN1)",
      "concept": {
        "name": "BECN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "041a53ee1e7ac18234901ba9412c345a"
    },
    {
      "bel": "p(HGNC:BECN1, pmod(Ph))",
      "concept": {
        "name": "BECN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "db0640f5f8f1c584ecb033eee96049dc",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:CCDC88A)",
      "concept": {
        "name": "CCDC88A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9f58f6742d37b33cc08d9e29ada7c6fe"
    },
    {
      "bel": "p(HGNC:CDK5)",
      "concept": {
        "name": "CDK5",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cb1e1b28f1d3fe30db837d601f26fe1b"
    },
    {
      "bel": "p(HGNC:CDK5R1)",
      "concept": {
        "name": "CDK5R1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "386aa7422eaa152faa763b873a474731"
    },
    {
      "bel": "p(HGNC:CDK5R1, frag(\"?\"))",
      "concept": {
        "name": "CDK5R1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7a0a57a21c416ed676dc05624cb52453",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:DISC1)",
      "concept": {
        "name": "DISC1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "119d7ded64ae942661a796d9d416306f"
    },
    {
      "bel": "p(HGNC:DISC1, var(\"?\"))",
      "concept": {
        "name": "DISC1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "969e106bd1cf69bca060148e42f8f5d1",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:DPYSL2)",
      "concept": {
        "name": "DPYSL2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "350bf2b3bff9a818ee59d1158e922f17"
    },
    {
      "bel": "p(HGNC:DRD1)",
      "concept": {
        "name": "DRD1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1e5b6d5cab598833f49049aafaa28b6e"
    },
    {
      "bel": "p(HGNC:DTNBP1)",
      "concept": {
        "name": "DTNBP1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "59c195c921e179c7267ba3a852fd18f8"
    },
    {
      "bel": "p(HGNC:ERBB4)",
      "concept": {
        "name": "ERBB4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "47fbed2d8914ddf8b9ea399ab49214d8"
    },
    {
      "bel": "p(HGNC:MAP1LC3A)",
      "concept": {
        "name": "MAP1LC3A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "89badabd301b21ede7de4f845c3e918f"
    },
    {
      "bel": "p(HGNC:MAP2)",
      "concept": {
        "name": "MAP2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "71faf2981c77262b2642092276929233"
    },
    {
      "bel": "p(HGNC:MAP6)",
      "concept": {
        "name": "MAP6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ec27b7a98eaef10ac0fa4047e1d84224"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0d2d8072f03dcdf148e658067d37b9cb",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MTOR)",
      "concept": {
        "name": "MTOR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a2450afd51fecb876f80e78722f0ba96"
    },
    {
      "bel": "p(HGNC:NRG1)",
      "concept": {
        "name": "NRG1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "340c84bad870d4aa1faafb6db24cf9ee"
    },
    {
      "bel": "p(HGNC:PRKAA1)",
      "concept": {
        "name": "PRKAA1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "94199d63c49af23978f439a18eff289a"
    },
    {
      "bel": "p(HGNC:PRKAA1, pmod(Ph))",
      "concept": {
        "name": "PRKAA1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e705de718b0199c6817a3e91eadceec1",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SLC18A2)",
      "concept": {
        "name": "SLC18A2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "51b1e125431b1a0ca0423c4c6c170a5f"
    },
    {
      "bel": "p(HGNC:SLC6A3)",
      "concept": {
        "name": "SLC6A3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e84110f26fe3cda6aef0ae6d680422c8"
    },
    {
      "bel": "p(HGNC:SNCA)",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8cd39bc202ad944395c27f63d95f6908"
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:misfolded))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c88a3d00124fd03746feda2e3f518a21",
      "variants": [
        {
          "concept": {
            "name": "misfolded",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"?\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "937de1ef5af195c85dd0c5e0fb175d14",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:TARDBP)",
      "concept": {
        "name": "TARDBP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d75da741c62ed3bc66c055d9cf679b6e"
    },
    {
      "bel": "p(HGNC:TARDBP, pmod(CONSO:misfolded))",
      "concept": {
        "name": "TARDBP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "27ae0183e6a13387ebc17a59d4f84a45",
      "variants": [
        {
          "concept": {
            "name": "misfolded",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:ULK1)",
      "concept": {
        "name": "ULK1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "26534d61ef0ff460d702bcedd67fa492"
    },
    {
      "bel": "p(HGNC:ULK1, pmod(Ph))",
      "concept": {
        "name": "ULK1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2ad781f2951a75c6482753da07994c1f",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:ULK1, var(\"?\"))",
      "concept": {
        "name": "ULK1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7fa7d54511bd949fc5db6af15c6a0f45",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:ULK2)",
      "concept": {
        "name": "ULK2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c3d15ac1033f3d1af9888605ab56d98e"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Dopamine receptors\")",
      "concept": {
        "name": "Dopamine receptors",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "574ffcc64c5f981384580d3a3d8de6d4"
    },
    {
      "bel": "p(MESH:Proteins)",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "5f95843f75d793290da323632314ec25"
    },
    {
      "bel": "p(MESH:Proteins, pmod(CONSO:misfolded))",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "b1b334ae55bd6774ab33678dc48e7bd6",
      "variants": [
        {
          "concept": {
            "name": "misfolded",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt)",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "a179f3829d42c3522d517c5ab2fc5b67"
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "27494583287536cfd1321001288923cd",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Rictor)",
      "concept": {
        "name": "Rictor",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "d7589ee5ac3b51ea8bf58d01b23e2cb0"
    },
    {
      "bel": "path(CONSO:Neurodegeneration)",
      "concept": {
        "name": "Neurodegeneration",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "e18248b0d7323caa29b448e45437a1e5"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Frontotemporal Dementia\")",
      "concept": {
        "name": "Frontotemporal Dementia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "876d8dfbadfb211122e2ba889d763c19"
    },
    {
      "bel": "path(MESH:\"Frontotemporal Lobar Degeneration\")",
      "concept": {
        "name": "Frontotemporal Lobar Degeneration",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "acfbc9fa7130c543db349bf00d56aaef"
    },
    {
      "bel": "path(MESH:\"Interpersonal Relations\")",
      "concept": {
        "name": "Interpersonal Relations",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "d43f4217c3e2ad9ae17157327d56bf94"
    },
    {
      "bel": "path(MESH:\"Lewy Body Disease\")",
      "concept": {
        "name": "Lewy Body Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "a7168678b41ade6ae6c13573a8c9a4e6"
    },
    {
      "bel": "path(MESH:\"Mental Disorders\")",
      "concept": {
        "name": "Mental Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e8512811f7721057e47dbfde4f38eb20"
    },
    {
      "bel": "path(MESH:\"Neurodegenerative Diseases\")",
      "concept": {
        "name": "Neurodegenerative Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "c04acd23e7e69b92e4e4230d8551fcf4"
    },
    {
      "bel": "path(MESH:\"Psychoses, Substance-Induced\")",
      "concept": {
        "name": "Psychoses, Substance-Induced",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "44a56186d855ea20631ff80e8e4dd71c"
    },
    {
      "bel": "path(MESH:\"Psychotic Disorders\")",
      "concept": {
        "name": "Psychotic Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ac78bb621180df12b3165a5ab9a57306"
    },
    {
      "bel": "path(MESH:Catatonia)",
      "concept": {
        "name": "Catatonia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "113b7ede906ca5297a52e26b012fd99d"
    },
    {
      "bel": "path(MESH:Delusions)",
      "concept": {
        "name": "Delusions",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "f816cd3221a06a2bab4ac6d1d01b36fa"
    },
    {
      "bel": "path(MESH:Hallucinations)",
      "concept": {
        "name": "Hallucinations",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6c7099fa6d88c62c91429eb0a6799043"
    },
    {
      "bel": "path(MESH:Schizophrenia)",
      "concept": {
        "name": "Schizophrenia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "af624e8cd364532e7f498f047527caac"
    },
    {
      "bel": "r(HGNC:ADNP)",
      "concept": {
        "name": "ADNP",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "2d20765d28a2aa11e24fb9295ff8930b"
    },
    {
      "bel": "r(HGNC:BECN1)",
      "concept": {
        "name": "BECN1",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "ea6978da638a2aa42949a8883b4d0913"
    },
    {
      "bel": "r(HGNC:CDK5)",
      "concept": {
        "name": "CDK5",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "dc7b07a0b4a4645a68dd1fb193369a16"
    },
    {
      "bel": "r(HGNC:MAP6)",
      "concept": {
        "name": "MAP6",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "cc9c30d32e48dbcae353a895d180b7cb"
    }
  ]
}